# EDGAR Filing Document

**Accession Number:** 0001735707
**File Stem:** 0001735707-25-000047
**Filing Date:** 2025-10
**Character Count:** 150351
**Document Hash:** 1e89d6c95173f4ae2b1e8f91dca14e06
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001735707-25-000047.hdr.sgml**: 20251023

**ACCESSION NUMBER**: 0001735707-25-000047

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 115

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251023

**DATE AS OF CHANGE**: 20251023

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Garrett Motion Inc.
- **CENTRAL INDEX KEY:** 0001735707
- **STANDARD INDUSTRIAL CLASSIFICATION:** MOTOR VEHICLE PARTS & ACCESSORIES [3714]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 824873189
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38636
- **FILM NUMBER:** 251411372

**BUSINESS ADDRESS:**
- **STREET 1:** LA PIECE 16
- **CITY:** ROLLE
- **STATE:** V8
- **ZIP:** 1180
- **BUSINESS PHONE:** 41-21-695-3000

**MAIL ADDRESS:**
- **STREET 1:** LA PIECE 16
- **CITY:** ROLLE
- **STATE:** V8
- **ZIP:** 1180

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Garrett Transportation Systems Inc.
- **DATE OF NAME CHANGE:** 20180327

?xml version='1.0' encoding='ASCII'? gtx-20250930

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, DC 20549**

________________________________________________

**FORM 10-Q**

________________________________________________

**(Mark One)**

**☒** **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended September 30, 2025**

**OR** 

**☐** **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from ______ to ______**

**Commission File Number: 001-38636**

________________________________________________

**Garrett Motion Inc.**

(Exact Name of Registrant as Specified in its Charter)

________________________________________________

---

| | |
|:---|:---|
| **Delaware** | **82-4873189** |
| (State or other jurisdiction of<br>incorporation or organization) | (I.R.S. Employer<br>Identification No.) |
| **47548 Halyard Drive, Plymouth, MI 48170** | **47548 Halyard Drive, Plymouth, MI 48170** |
| and | and |
| **La Pièce 16, 1180 Rolle, Switzerland** | **La Pièce 16, 1180 Rolle, Switzerland** |
| **(Address of principal executive offices) (Zip Code)** | **(Address of principal executive offices) (Zip Code)** |

---

---

| |
|:---|
| **+1 734 392 5500** |
| and |
| **+41 21 695 30 00** |

---

**(Registrant's telephone number, including area code)**

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, $0.001 par value per share | GTX | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | **☒** | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| Emerging growth company | ☐ | | |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes ☒ No ☐

As of October 17, 2025, the registrant had 194,482,518 shares of Common Stock, $0.001 par value per share, outstanding.

------

**Table of Contents**

---

| | | |
|:---|:---|:---|
|  |  | **Page** |
| **[PART I.](#i34f4828392be4d5b9e06df605358c33f_10)** | <u>[FINANCIAL INFORMATION](#i34f4828392be4d5b9e06df605358c33f_10)</u> | [2](#i34f4828392be4d5b9e06df605358c33f_10) |
| [Item 1.](#i34f4828392be4d5b9e06df605358c33f_13) | <u>[Financial Statements (Unaudited)](#i34f4828392be4d5b9e06df605358c33f_13)</u> | [2](#i34f4828392be4d5b9e06df605358c33f_13) |
|  | <u>[Consolidated Interim Statements of Operations (Unaudited)](#i34f4828392be4d5b9e06df605358c33f_16)</u> | [2](#i34f4828392be4d5b9e06df605358c33f_16) |
|  | <u>[Consolidated Interim Statements of Comprehensive Income (Unaudited)](#i34f4828392be4d5b9e06df605358c33f_19)</u> | [3](#i34f4828392be4d5b9e06df605358c33f_19) |
|  | <u>[Consolidated Interim Balance Sheets (Unaudited)](#i34f4828392be4d5b9e06df605358c33f_22)</u> | [4](#i34f4828392be4d5b9e06df605358c33f_22) |
|  | <u>[Consolidated Interim Statements of Cash Flows (Unaudited)](#i34f4828392be4d5b9e06df605358c33f_25)</u> | [5](#i34f4828392be4d5b9e06df605358c33f_25) |
|  | <u>[Consolidated Interim Statements of Equity (Deficit) (Unaudited)](#i34f4828392be4d5b9e06df605358c33f_28)</u> | [6](#i34f4828392be4d5b9e06df605358c33f_28) |
|  | <u>[Notes to Consolidated Interim Financial Statements](#i34f4828392be4d5b9e06df605358c33f_31)</u> (<u>[Unaudited](#i34f4828392be4d5b9e06df605358c33f_31)</u>) | [8](#i34f4828392be4d5b9e06df605358c33f_31) |
| [Item 2.](#i34f4828392be4d5b9e06df605358c33f_106) | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i34f4828392be4d5b9e06df605358c33f_106)</u> | [27](#i34f4828392be4d5b9e06df605358c33f_106) |
| [Item 3.](#i34f4828392be4d5b9e06df605358c33f_127) | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i34f4828392be4d5b9e06df605358c33f_127)</u> | [38](#i34f4828392be4d5b9e06df605358c33f_127) |
| [Item 4.](#i34f4828392be4d5b9e06df605358c33f_130) | <u>[Controls and Procedures](#i34f4828392be4d5b9e06df605358c33f_130)</u> | [39](#i34f4828392be4d5b9e06df605358c33f_130) |
| **[PART II.](#i34f4828392be4d5b9e06df605358c33f_133)** | <u>[OTHER INFORMATION](#i34f4828392be4d5b9e06df605358c33f_133)</u> | [40](#i34f4828392be4d5b9e06df605358c33f_133) |
| [Item 1.](#i34f4828392be4d5b9e06df605358c33f_136) | <u>[Legal Proceedings](#i34f4828392be4d5b9e06df605358c33f_136)</u> | [40](#i34f4828392be4d5b9e06df605358c33f_136) |
| [Item 1A.](#i34f4828392be4d5b9e06df605358c33f_139) | <u>[Risk Factors](#i34f4828392be4d5b9e06df605358c33f_139)</u> | [40](#i34f4828392be4d5b9e06df605358c33f_139) |
| [Item 2.](#i34f4828392be4d5b9e06df605358c33f_142) | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i34f4828392be4d5b9e06df605358c33f_142)</u> | [40](#i34f4828392be4d5b9e06df605358c33f_142) |
| [Item 3.](#i34f4828392be4d5b9e06df605358c33f_145) | <u>[Defaults Upon Senior Securities](#i34f4828392be4d5b9e06df605358c33f_145)</u> | [40](#i34f4828392be4d5b9e06df605358c33f_145) |
| [Item 4.](#i34f4828392be4d5b9e06df605358c33f_148) | <u>[Mine Safety Disclosures](#i34f4828392be4d5b9e06df605358c33f_148)</u> | [40](#i34f4828392be4d5b9e06df605358c33f_148) |
| [Item 5.](#i34f4828392be4d5b9e06df605358c33f_151) | <u>[Other Information](#i34f4828392be4d5b9e06df605358c33f_151)</u> | [41](#i34f4828392be4d5b9e06df605358c33f_151) |
| [Item 6.](#i34f4828392be4d5b9e06df605358c33f_154) | <u>[Exhibits](#i34f4828392be4d5b9e06df605358c33f_154)</u> | [41](#i34f4828392be4d5b9e06df605358c33f_154) |
| <u>[Signatures](#i34f4828392be4d5b9e06df605358c33f_157)</u> | <u>[Signatures](#i34f4828392be4d5b9e06df605358c33f_157)</u> | [43](#i34f4828392be4d5b9e06df605358c33f_157) |

---

------

**PART I—FINANCIAL INFORMATION**

**Item 1. Financial Statements**

**GARRETT MOTION INC.**

**CONSOLIDATED INTERIM STATEMENTS OF OPERATIONS** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions, except per share amounts)** | **(Dollars in millions, except per share amounts)** | **(Dollars in millions, except per share amounts)** | **(Dollars in millions, except per share amounts)** |
| Net sales (Note 3) | $902 | $826 | $2693 | $2631 |
| Cost of goods sold | 716 | 660 | 2147 | 2108 |
| Gross profit | 186 | 166 | 546 | 523 |
| Selling, general and administrative expenses | 57 | 53 | 175 | 178 |
| Other expense, net | 1 | 1 | 9 | 5 |
| Interest expense | 29 | 37 | 83 | 130 |
| Gain on sale of equity investment (Note 22) |  |  |  | (27) |
| Non-operating income, net | (3) | (1) | (10) | (7) |
| Income before taxes | 102 | 76 | 289 | 244 |
| Tax expense (Note 5) | 25 | 24 | 63 | 62 |
| Net income | $77 | $52 | $226 | $182 |
| Earnings per common share |  |  |  |  |
| Basic | $0.39 | $0.24 | $1.12 | $0.80 |
| Diluted | 0.38 | 0.24 | 1.10 | 0.80 |
| Weighted average common shares outstanding |  |  |  |  |
| Basic | 198668143 | 217283749 | 202127953 | 226057803 |
| Diluted | 202194334 | 218403681 | 205130616 | 227649747 |

---

The Notes to the Consolidated Interim Financial Statements are an integral part of this statement.

------

**GARRETT MOTION INC.** 

**CONSOLIDATED INTERIM STATEMENTS OF COMPREHENSIVE INCOME**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Net income | $77 | $52 | $226 | $182 |
| Foreign exchange translation adjustment | 3 | (30) | (85) | (12) |
| Defined benefit pension plan adjustment, net of tax |  | 1 |  | 4 |
| Changes in fair value of effective cash flow hedges, net of tax (Note 16) | 5 | 4 | 24 | 5 |
| Changes in fair value of net investment hedges, net of tax (Note 16) | 5 | (31) | (158) | (4) |
| Total other comprehensive income (loss), net of tax | 13 | (56) | (219) | (7) |
| Comprehensive income (loss) | $90 | $(4) | $7 | $175 |

---

The Notes to the Consolidated Interim Financial Statements are an integral part of this statement.

------

**GARRETT MOTION INC.** 

**CONSOLIDATED INTERIM BALANCE SHEETS** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **September 30,<br>2025** | **December 31,<br>2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| **ASSETS** | | |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $230 | $125 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash | 2 | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts, notes and other receivables – net (Note 6) | 719 | 687 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories – net (Note 8) | 320 | 286 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current assets | 109 | 94 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 1380 | 1193 |
| Investments and long-term receivables | 11 | 10 |
| Property, plant and equipment – net | 452 | 449 |
| Goodwill | 193 | 193 |
| Deferred income taxes | 247 | 207 |
| Other assets (Note 9) | 153 | 224 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $2436 | $2276 |
| **LIABILITIES** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $1022 | $972 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current maturities of long-term debt (Note 14) | 7 | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities (Note 11) | 330 | 299 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 1359 | 1278 |
| Long-term debt (Note 14) | 1460 | 1464 |
| Deferred income taxes | 54 | 25 |
| Other liabilities (Note 12) | 376 | 182 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $3249 | $2949 |
| **COMMITMENTS AND CONTINGENCIES** (Note 19) |  |  |
| **EQUITY (DEFICIT)** |  |  |
| Common Stock, par value $0.001; 1,000,000,000 and 1,000,000,000 shares authorized, 242,502,188 and 240,987,329 issued and 195,105,105 and 206,387,938 outstanding as of September 30, 2025 and December 31, 2024, respectively  |  |  |
| Additional paid–in capital | 1232 | 1213 |
| Retained deficit | (1452) | (1653) |
| Accumulated other comprehensive (loss) income (Note 17) | (146) | 73 |
| Treasury Stock, at cost; 47,397,083 and 34,599,391 shares as of September 30, 2025 and December 31, 2024, respectively (Note 15) | (447) | (306) |
| Total deficit | (813) | (673) |
| Total liabilities and deficit | $2436 | $2276 |

---

The Notes to the Consolidated Interim Financial Statements are an integral part of this statement.

------

**GARRETT MOTION INC.** 

**CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | &nbsp;&nbsp;&nbsp;&nbsp;**Nine Months Ended September 30,** | &nbsp;&nbsp;&nbsp;&nbsp;**Nine Months Ended September 30,** |
| | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| **Cash flows from operating activities:** |  |  |
| Net income | $226 | $182 |
| Adjustments to reconcile net income to net cash provided by operating activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | (8) | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 70 | 67 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of deferred issuance costs | 5 | 35 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of equity investment |  | (27) |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange gain | (66) | (10) |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock compensation expense | 19 | 17 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension expense | 1 | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Unrealized loss on derivatives | 75 | 39 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 10 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts, notes and other receivables | 4 | 110 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (17) | (10) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | (14) | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | (2) | (154) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | (10) | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other liabilities | 21 | (1) |
| Net cash provided by operating activities | $314 | $277 |
| **Cash flows from investing activities:** |  |  |
| Expenditures for property, plant and equipment | (51) | (69) |
| Proceeds from cross-currency swap contracts | 21 | 24 |
| Proceeds from sale of equity investment | 3 | 46 |
| Net cash (used for) provided by investing activities | $(27) | $1 |
| **Cash flows from financing activities:** |  |  |
| Proceeds from issuance of long-term debt, net of debt financing costs | 80 | 794 |
| Payments of long-term debt | (87) | (991) |
| Repurchases of Common Stock | (136) | (226) |
| Excise tax on Common Stock repurchase | (3) |  |
| Dividend payments | (36) |  |
| Payments for debt and revolving facility financing costs | (2) | (7) |
| Other | (3) | (9) |
| Net cash used for financing activities | $(187) | $(439) |
| Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | 6 | (2) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 106 | (163) |
| Cash, cash equivalents and restricted cash at beginning of the period | 126 | 260 |
| Cash, cash equivalents and restricted cash at end of the period | $232 | $97 |
| **Supplemental cash flow disclosure:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes paid (net of refunds) | $50 | $43 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest paid | 57 | 49 |

---

&nbsp;&nbsp;&nbsp;&nbsp;

The Notes to the Consolidated Interim Financial Statements are an integral part of this statement

------

**GARRETT MOTION INC.** 

**CONSOLIDATED INTERIM STATEMENTS OF EQUITY (DEFICIT)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Common Stock** | **Common Stock** | **Treasury Stock** | **Treasury Stock** | **Additional<br>Paid-in <br>Capital** | **Retained <br>Deficit** | **Accumulated Other <br>Comprehensive Income / (Loss)** | **Total <br>Deficit** |
| | **Shares** <sup>(1)</sup> | **Amount** | **Shares** | **Amount** | **Additional<br>Paid-in <br>Capital** | **Retained <br>Deficit** | **Accumulated Other <br>Comprehensive Income / (Loss)** | **Total <br>Deficit** |
| | **(in millions)** | **(in millions)** | **(in millions)** | **(in millions)** | **(in millions)** | **(in millions)** | **(in millions)** | **(in millions)** |
| Balance at December 31, 2024 | 241 | $— | 35 | $(306) | $1213 | $(1653) | $73 | $(673) |
| Net income |  |  |  |  |  | 62 |  | 62 |
| Share repurchases |  |  | 3 | (30) |  |  |  | (30) |
| Shares issued under stock plan, net of shares withheld for employee taxes | 1 |  |  | (3) |  |  |  | (3) |
| Other comprehensive loss, net of tax |  |  |  |  |  |  | (62) | (62) |
| Stock-based compensation |  |  |  |  | 6 |  |  | 6 |
| Balance at March 31, 2025 | 242 | $— | 38 | $(339) | $1219 | $(1591) | $11 | $(700) |
| Net income |  |  |  |  |  | 87 |  | 87 |
| Share repurchases |  |  | 3 | (22) |  |  |  | (22) |
| Shares issued under stock plan, net of shares withheld for employee taxes |  |  |  | (1) |  |  |  | (1) |
| Other comprehensive loss, net of tax |  |  |  |  |  |  | (170) | (170) |
| Dividends |  |  |  |  |  | (13) |  | (13) |
| Stock-based compensation |  |  |  |  | 7 |  |  | 7 |
| Balance at June 30, 2025 | 242 | $— | 41 | $(362) | $1226 | $(1517) | $(159) | $(812) |
| Net income |  |  |  |  |  | 77 |  | 77 |
| Share repurchases |  |  | 6 | (84) |  |  |  | (84) |
| Excise tax on share repurchases |  |  |  | (1) |  |  |  | (1) |
| Other comprehensive income, net of tax |  |  |  |  |  |  | 13 | 13 |
| Dividends |  |  |  |  |  | (12) |  | (12) |
| Stock-based compensation |  |  |  |  | 6 |  |  | 6 |
| Balance at September 30, 2025 | 242 | $— | 47 | $(447) | $1232 | $(1452) | $(146) | $(813) |

---

------

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Common Stock** | **Common Stock** | **Treasury Stock** | **Treasury Stock** | **Additional<br>Paid-in <br>Capital** | **Retained <br>Deficit** | **Accumulated Other <br>Comprehensive (Loss) / Income** | **Total <br>Deficit** |
| | **Shares** <sup>(1)</sup> | **Amount** | **Shares** | **Amount** | **Additional<br>Paid-in <br>Capital** | **Retained <br>Deficit** | **Accumulated Other <br>Comprehensive (Loss) / Income** | **Total <br>Deficit** |
| | **(in millions)** | **(in millions)** | **(in millions)** | **(in millions)** | **(in millions)** | **(in millions)** | **(in millions)** | **(in millions)** |
| Balance at December 31, 2023 | 238 | $— |  | $— | $1190 | $(1922) | $(3) | $(735) |
| Net income |  |  |  |  |  | 66 |  | 66 |
| Share repurchases |  |  | 12 | (109) |  |  |  | (109) |
| Excise tax on share repurchases |  |  |  | (1) |  |  |  | (1) |
| Shares issued under stock plan, net of shares withheld for employee taxes | 2 |  | 1 | (5) |  |  |  | (5) |
| Other comprehensive income, net of tax |  |  |  |  |  |  | 41 | 41 |
| Stock-based compensation |  |  |  |  | 8 |  |  | 8 |
| Balance at March 31, 2024 | 240 | $— | 13 | $(115) | $1198 | $(1856) | $38 | $(735) |
| Net income |  |  |  |  |  | 64 |  | 64 |
| Share repurchases |  |  | 7 | (65) |  |  |  | (65) |
| Excise tax on share repurchases |  |  |  | (1) |  |  |  | (1) |
| Shares issued under stock plan, net of shares withheld for employee taxes | 1 |  |  | (1) |  |  |  | (1) |
| Other comprehensive income, net of tax |  |  |  |  |  |  | 8 | 8 |
| Stock-based compensation |  |  |  |  | 5 |  |  | 5 |
| Balance at June 30, 2024 | 241 | $— | 20 | $(182) | $1203 | $(1792) | $46 | $(725) |
| Net income |  |  |  |  |  | 52 |  | 52 |
| Repurchases of Common Stock |  |  | 6 | (52) |  |  |  | (52) |
| Excise tax on share repurchases |  |  |  |  |  |  |  |  |
| Shares issued under stock plan, net of shares withheld for employee taxes |  |  |  | (1) |  |  |  | (1) |
| Other comprehensive loss, net of tax |  |  |  |  |  |  | (56) | (56) |
| Stock-based compensation |  |  |  |  | 4 |  |  | 4 |
| Balance at September 30, 2024 | 241 | $— | 26 | $(235) | $1207 | $(1740) | $(10) | $(778) |

---

1) Common shares issued less treasury shares equals common shares outstanding

The Notes to the Consolidated Interim Financial Statements are an integral part of this statement.

------

**GARRETT MOTION INC.** 

**NOTES TO CONSOLIDATED INTERIM FINANCIAL STATEMENTS**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(Unaudited)**

**(Dollars in millions, except per share amounts)**

**Note 1. Background and Basis of Presentation**

***Background***

Garrett Motion Inc. (the "Company" or "Garrett") is a cutting-edge technology leader delivering differentiated solutions for emission reduction and energy efficiency. We design, manufacture, and sell highly engineered turbocharging, air and fluid compression, and high-speed electric motor technologies to original equipment manufacturers ("OEMs") and distributors within the mobility and industrial space. We have significant expertise in delivering products at scale for internal combustion engines using gasoline, diesel, natural gas, and hydrogen, as well as for zero-emission technologies using hydrogen fuel cell systems, both for mobility and industrial use. As our customers continue to progress on electrification, we are applying our technological pillars to develop highly engineered E-Powertrain and E-Cooling compressor products to support their ambition. These products are key enablers for fuel economy, energy efficiency, thermal management, and compliance with emissions standards and overall greenhouse gas and other emission reduction targets.

***Basis of Presentation***

The accompanying unaudited Consolidated Interim Financial Statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission ("SEC") applicable to interim financial statements. While these statements reflect all normal recurring adjustments that are, in the opinion of management, necessary for fair presentation of the results of the interim period, they do not include all of the information and footnotes required by United States generally accepted accounting principles ("GAAP") for complete financial statements. The unaudited Consolidated Interim Financial Statements should therefore be read in conjunction with the Consolidated Financial Statements and accompanying notes for the year ended December 31, 2024 included in our Annual Report on Form 10-K, as filed with the SEC on February 20, 2025 (our "2024 Form 10-K"). The results of operations for the three and nine months ended September 30, 2025 and cash flows for the nine months ended September 30, 2025 should not necessarily be taken as indicative of the entire year. All amounts presented are in millions, except per share amounts.

We evaluate segment reporting in accordance with ASC 280, *Segment Reporting*. We concluded that Garrett operates in a single operating segment and a single reportable segment based on the operating results available and evaluated regularly by the chief operating decision maker ("CODM"), which is our Chief Executive Officer, to make decisions about resource allocation and performance assessment. The CODM makes operational performance assessments and resource allocation decisions on a consolidated basis, inclusive of all of the Company's products across channels and geographies.

The preparation of the financial statements in conformity with GAAP requires management to make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases these estimates on assumptions that it believes to be reasonable under the circumstances. Actual results could differ from the original estimates, requiring adjustments to these balances in future periods.

**Note 2. Summary of Significant Accounting Policies** 

The accounting policies of the Company are set forth in Note 3 to the Consolidated Financial Statements for the year ended December 31, 2024 included in our 2024 Form 10-K.

------

***Recently Adopted Accounting Pronouncements***

In December 2023, the FASB issued ASU 2023-09, *Income Taxes (Topic 740): Improvements to Income Tax Disclosures*. The amendments in this update increase the transparency around income tax information through improvements to disclosures primarily related to the rate reconciliation and income taxes paid information. The Company adopted the new guidance prospectively as of January 1, 2025.

***Accounting Standards Issued But Not Yet Adopted***

In March 2024, the SEC adopted a final rule under SEC Release No. 33-11275, *The Enhancement and Standardization of Climate-Related Disclosures for Investors*, to enhance and standardize climate-related disclosures. The rule will require companies to disclose material Scope 1 and Scope 2 greenhouse gas emissions; climate-related risks, governance, and oversight; and the financial effects of severe weather events and other natural conditions. These disclosures are required to be phased in starting with annual reporting periods beginning in 2025; however, this rule has been stayed pending the outcome of legal challenges, and on March 27, 2025, the SEC withdrew its legal defense of the rule. The Company is currently evaluating the guidance to determine the impact of adoption on its disclosures in the event that the stay is lifted.

In November 2024, the FASB issued ASU 2024-03, *Income Statement*—*Reporting Comprehensive Income*—*Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.* The amendments in this update require disclosure of specified information about certain costs and expenses. The guidance is effective for fiscal years beginning after December 15, 2026 on a prospective basis. Early adoption is permitted. The Company is currently evaluating the guidance to determine the impact on its disclosures.

In September 2025, FASB issued ASU 2025-06, *Intangibles*—*Goodwill and Other*—*Internal Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software.* The amendments revise the capitalization criteria for internal-use software costs and eliminate stage-based development guidance. The update is effective for fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the guidance to determine the impact on its accounting policies and disclosures.

There are no other recently issued, but not yet adopted, accounting pronouncements that are expected to have a material impact on the Company's Consolidated Interim Financial Statements and related disclosures.

**Note 3. Revenue Recognition and Contracts with Customers** 

***Disaggregated Revenue***

Net sales by region (determined based on country of shipment) and channel is included in Note 21, *Segments and Concentrations*.

***Contract Balances***

The following table summarizes our contract assets and liabilities balances:

---

| | | |
|:---|:---|:---|
| | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Contract assets—January 1 | $40 | $38 |
| Contract assets—September 30 | 48 | 53 |
| Change in contract assets—Increase/(Decrease) | $8 | $15 |
| Contract liabilities—January 1 | $(8) | $(11) |
| Contract liabilities—September 30 | (6) | (9) |
| Change in contract liabilities—Decrease/(Increase) | $2 | $2 |

---

**Note 4. Research, Development and Engineering**

Garrett conducts research, development, and engineering ("RD&E") activities, which consist primarily of the

------

development of new products and product applications. RD&E costs are charged to expense as incurred unless the Company has a contractual guarantee for reimbursement from the customer. Customer reimbursements are netted against gross RD&E expenditures as they are considered a recovery of cost. Such costs are included in Cost of goods sold as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Research and development costs | $46 | $49 | $136 | $138 |
| Engineering-related expenses, net <sup>(1)</sup> | (13) | (6) | (18) | (10) |
|  | $33 | $43 | $118 | $128 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;&nbsp;&nbsp;&nbsp;Engineering-related expenses are net of customer reimbursements and costs capitalized from contractual guarantees of reimbursement of $23 million and $17 million for the three months ended September 30, 2025 and 2024, respectively, and $48 million and $41 million for the nine months ended September 30, 2025 and 2024, respectively.

Certain engineering expenses related to long-term supply arrangements are capitalized when defined criteria, such as the existence of a contractual guarantee for reimbursement, are met. As of September 30, 2025 and December 31, 2024, $49 million and $29 million, respectively, of such contractually reimbursable costs were capitalized. These amounts are recorded within Other current assets and Other assets in the Consolidated Interim Balance Sheet.

**Note 5. Income Taxes**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Tax expense | $25 | $24 | $63 | $62 |
| Effective tax rate | 24.5% | 31.6% | 21.8% | 25.4% |

---

The effective tax rates for the three months ended September 30, 2025 and 2024 were 24.5% and 31.6%, respectively. The effective tax rates for the nine months ended September 30, 2025 and 2024 were 21.8% and 25.4%, respectively.

The change in the effective tax rate for the three months ended September 30, 2025 compared to the prior period is primarily related to a decrease in U.S. taxes on international operations and the global mix of earnings.

The change in the effective tax rate for the nine months ended September 30, 2025 compared to the prior period is primarily related to a one-time benefit attributable to the revaluation of deferred tax assets in China.

The effective tax rate for the three months ended September 30, 2025 was higher than the U.S. federal statutory rate of 21% primarily because of U.S. taxes on international operations partially offset by lower taxes on non-U.S. earnings and global research and development benefits.

The effective tax rate for the nine months ended September 30, 2025 was higher than the U.S. federal statutory rate of 21% primarily because of U.S. taxes on international operations. This increase was partially offset by a one-time benefit attributable to the revaluation of deferred tax assets in China as well as lower taxes on non-U.S. earnings and global research and development benefits.

**Note 6. Accounts, Notes and Other Receivables—Net**

---

| | | |
|:---|:---|:---|
| | **September 30,<br>2025** | **December 31,<br>2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Trade receivables | $608 | $521 |

---

------

---

| | | |
|:---|:---|:---|
| Notes receivable | 55 | 96 |
| Other receivables  | 62 | 74 |
|  | 725 | 691 |
| Less—Allowance for expected credit losses | (6) | (4) |
|  | $719 | $687 |

---

Trade receivables include $48 million and $40 million of unbilled customer contract asset balances as of September 30, 2025 and December 31, 2024, respectively. These amounts are billed in accordance with the terms of customer contracts to which they relate. See Note 3*, Revenue Recognition and Contracts with Customers*.

Notes receivable is related to guaranteed bank notes without recourse that the Company receives in settlement of accounts receivables, primarily in the Asia Pacific region. See Note 7, *Factoring and Notes Receivable*.

Other receivables includes VAT receivables of $46 million and $50 million as of September 30, 2025 and December 31, 2024, respectively.

**Note 7. Factoring and Notes Receivable**

The Company enters into arrangements with financial institutions to sell eligible trade receivables. The receivables are sold without recourse and the Company accounts for these arrangements as true sales. The Company also receives guaranteed bank notes without recourse, in settlement of accounts receivables, primarily in the Asia Pacific region. The Company can hold the bank notes until maturity, exchange them with suppliers to settle liabilities, or sell them to third-party financial institutions in exchange for cash. Bank notes sold to third-party financial institutions without recourse are likewise accounted for as true sales.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Eligible receivables sold without recourse | $191 | $140 | $533 | $542 |
| Guaranteed bank notes sold without recourse | 61 | 95 | 157 | 147 |

---

The expenses related to the sale of trade receivables and guaranteed bank notes are recognized within Other expense, net in the Consolidated Interim Statements of Operations, and were $— million and $1 million for the three months ended September 30, 2025 and 2024, respectively, and $2 million and $3 million for the nine months ended September 30, 2025 and 2024, respectively.

---

| | | |
|:---|:---|:---|
| | **September 30,<br>2025** | **December 31,<br>2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Receivables sold but not yet collected by the bank from the customer | $1 | $6 |
| Guaranteed bank notes sold but not yet collected by the bank from the customer | 45 |  |

---

As of September 30, 2025 and December 31, 2024, the Company had no guaranteed bank notes pledged as collateral.

------

**Note 8. Inventories—Net** 

---

| | | |
|:---|:---|:---|
| | **September 30,<br>2025** | **December 31,<br>2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Raw materials | $253 | $230 |
| Work in process | 23 | 18 |
| Finished products | 89 | 79 |
|  | 365 | 327 |
| Less—Reserves | (45) | (41) |
|  | $320 | $286 |

---

**Note 9. Other Assets**

---

| | | |
|:---|:---|:---|
| | **September 30,<br>2025** | **December 31,<br>2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Advanced discounts to customers, non-current | $22 | $29 |
| Operating right-of-use assets (Note 13) | 51 | 52 |
| Income tax receivable | 21 | 21 |
| Pension and other employee related | 26 | 23 |
| Customer reimbursable engineering costs | 23 |  |
| Derivatives designated as net investment hedges (Note 16) | 2 | 70 |
| Designated and undesignated derivatives (Note 16) |  | 20 |
| Other | 8 | 9 |
|  | $153 | $224 |

---

**Note 10. Supplier Financing**

The Company has supplier financing arrangements with two third-party financial institutions under which certain suppliers may factor their receivables from Garrett. The Company also enters into arrangements with banking institutions to issue bankers acceptance drafts in settlement of accounts payables, primarily in the Asia Pacific region. The bankers acceptance drafts, or guaranteed bank notes, have a contractual maturity of six months or less, and may be held by suppliers until maturity, transferred to their suppliers, or discounted with financial institutions in exchange for cash. The supplier financing obligations and guaranteed bank notes outstanding are recorded within Accounts payable in our Consolidated Interim Balance Sheet.

---

| | | |
|:---|:---|:---|
| | **September 30,<br>2025** | **December 31,<br>2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Supplier financing obligations outstanding with financial institutions | $71 | $64 |
| Guaranteed bank notes outstanding | 152 | 141 |

---

**Note 11. Accrued Liabilities** 

---

| | | |
|:---|:---|:---|
| | **September 30,<br>2025** | **December 31,<br>2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Customer pricing reserve | $99 | $77 |
| Compensation, benefit and other employee related | 78 | 74 |
| Repositioning | 10 | 12 |
| Product warranties and performance guarantees - short-term (Note 19) | 14 | 15 |
| Income and other taxes | 39 | 32 |

---

------

---

| | | |
|:---|:---|:---|
| Customer advances and deferred income <sup>(1)</sup> | 13 | 16 |
| Accrued interest | 28 | 14 |
| Short-term lease liability (Note 13) | 13 | 11 |
| Accrued freight | 9 | 9 |
| Dividends payable |  | 12 |
| Designated and undesignated derivatives (Note 16)  | 10 | 8 |
| Environmental reserve | 4 | 6 |
| Other (primarily operating expenses) | 13 | 13 |
|  | 330 | 299 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Customer advances and deferred income include $6 million and $8 million of contract liabilities as of September 30, 2025 and December 31, 2024, respectively. See Note 3, *Revenue Recognition and Contracts with Customers*.

The Company accrues repositioning costs related to projects to optimize its product costs and right-size our organizational structure. Expenses related to the repositioning accruals are included in Cost of goods sold and Selling, general and administrative expenses in our Consolidated Interim Statements of Operations.

The following tables summarize the activity in our repositioning accrual:

---

| | | | |
|:---|:---|:---|:---|
| | **Severance Costs** | **Other Costs** | **Total** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Balance at December 31, 2024 | $12 | $— | $12 |
| &nbsp;&nbsp;&nbsp;&nbsp;Charges | 8 |  | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Usage—cash | (10) |  | (10) |
| Balance at September 30, 2025 | $10 | $— | $10 |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Severance Costs** | **Other Costs** | **Total** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Balance at December 31, 2023 | $9 | $— | $9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Charges | 16 |  | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;Usage—cash | (15) |  | (15) |
| Balance at September 30, 2024 | $10 | $— | $10 |

---

**Note 12. Other Liabilities**

---

| | | |
|:---|:---|:---|
| | **September 30,<br>2025** | **December 31,<br>2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Income taxes | $92 | $79 |
| Designated and undesignated derivatives (Note 16) | 187 | 3 |
| Pension and other employee related | 18 | 18 |
| Long-term lease liability (Note 13) | 40 | 42 |
| Advanced discounts from suppliers | 2 | 2 |
| Product warranties and performance guarantees – long-term (Note 19) | 8 | 8 |
| Environmental remediation – long term | 11 | 10 |
| Long-term accounts payable | 3 | 5 |
| Asset retirement obligation | 8 | 8 |
| Other | 7 | 7 |
|  | 376 | 182 |

---

------

**Note 13. Leases**

We have operating leases that primarily consist of real estate, machinery, and equipment. As of September 30, 2025, the Company does not have any material finance leases. Our leases have remaining lease terms of up to 12 years, some of which include options to extend the leases for up to two years, and some of which include options to terminate the leases within the year.

The components of lease expense are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Operating lease cost | $4 | $4 | $13 | $11 |
| Short-term lease cost |  |  | 1 |  |
| Total lease cost | $4 | $4 | $14 | $11 |

---

Supplemental cash flow information related to operating leases is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Cash paid for amounts included in the measurement of lease liabilities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating cash outflows from operating leases | $4 | $4 | $12 | $10 |
| Right-of-use assets obtained in exchange for lease obligations: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating leases |  | 1 | 4 | 10 |

---

Supplemental balance sheet information related to operating leases is as follows:

---

| | | |
|:---|:---|:---|
| | **September 30,<br>2025** | **December 31,<br>2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Other assets | $51 | $52 |
| Accrued liabilities | 13 | 11 |
| Other liabilities | 40 | 42 |

---

---

| | | |
|:---|:---|:---|
| | **September 30,<br>2025** | **December 31, 2024** |
| Weighted-average remaining lease term (in years) | 6.59 | 6.89 |
| Weighted-average discount rate | 6.44% | 6.71% |

---

------

Maturities of operating lease liabilities as of September 30, 2025 were as follows:

---

| | |
|:---|:---|
| | **(Dollars in millions)** |
| 2025 | $4 |
| 2026 | 15 |
| 2027 | 12 |
| 2028 | 8 |
| 2029 | 5 |
| Thereafter | 19 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total lease payments | 63 |
| Less imputed interest | (10) |
|  | $53 |

---

**Note 14. Long-Term Debt and Credit Agreements**

***Senior Notes***

On May 21, 2024, Garrett Motion Holdings Inc. and Garrett LX I S.à.r.l. (the "Issuers"), wholly owned subsidiaries of the Company, completed an offering of $800 million in aggregate principal amount of 7.75% Senior Unsecured Notes due 2032 (the "2032 Senior Notes"). The 2032 Senior Notes mature on May 31, 2032. The Company incurred $12 million of debt issuance costs, which have been capitalized and will be amortized on a straight-line basis.

The 2032 Senior Notes are guaranteed by the Company and each of the Company's wholly owned subsidiaries that guarantee obligations under the Credit Agreement (as defined below), subject to certain exceptions. The proceeds from the sale of the 2032 Senior Notes, together with cash on hand, were used to repay approximately $800 million of term loan indebtedness and to pay related fees and expenses. The 2032 Senior Notes bear interest at a rate of 7.75% per annum. Interest on the 2032 Senior Notes is payable semi-annually in arrears on May 31 and November 30 of each year, commencing on November 30, 2024.

The 2032 Senior Notes indenture contains certain covenants that limit the ability of the Company and its restricted subsidiaries to incur certain additional debt, incur certain liens securing debt, pay certain dividends or make other restricted payments, make certain investments, make certain asset sales, and enter into certain transactions with affiliates. These covenants are subject to a number of exceptions, limitations, and qualifications as set forth in the 2032 Senior Notes indenture. Additionally, the indenture contains certain change of control provisions that, under certain conditions, would require the Company to make an offer to repurchase all of the outstanding 2032 Senior Notes at a price equal to 101% of the aggregate principal amount, plus accrued and unpaid interest. The indenture also contains customary events of default.

***Credit Facilities***

On January 30, 2025, the Company entered into that certain Restatement Agreement (the "Restatement Agreement"), which amends and restates that certain Credit Agreement, dated as of April 30, 2021 (as amended from time to time, the "Existing Credit Agreement" and as amended and restated by the Restatement Agreement, the "Credit Agreement"), by and among the Company, Garrett Motion Holdings Inc., Garrett Motion Sàrl and Garrett LX I S.à.r.l., as borrowers (the "Borrowers"), the lenders and issuing banks part thereto from time to time, and JPMorgan Chase Bank, N.A., as administrative agent. Under the Restatement Agreement, the Company refinanced in full its $692 million U.S. Dollar term loan facility (the "2021 Dollar Term Facility") under the Existing Credit Agreement with a new $692 million term loan (the "2025 Dollar Term Facility") in an aggregate principal amount of $692 million. The 2025 Dollar Term Facility will mature on January 30, 2032, and initially bore interest at a rate equal to, at the Company's option, the Adjusted Term SOFR Rate (as defined in the Restatement Agreement) plus 2.25% per annum in the case of Term Benchmark Loans (as defined in the Restatement Agreement) and the Alternate Base Rate (as defined in the Restatement Agreement) plus 1.25% per annum in the case of ABR Loans (as defined in the Restatement Agreement). On August 6, 2025, the Company entered into Amendment No. 1 (the "First Amendment") to the Restatement Agreement, which reduced the Applicable Rate (as defined

------

in the Restatement Agreement) to the Adjusted Term SOFR Rate plus 2.00% per annum in the case of Term Benchmark Loans and the Alternate Base Rate plus 1.00% per annum in the case of ABR Loans.

Also on January 30, 2025, pursuant to the Restatement Agreement, the Company replaced its existing $600 million revolving commitments under the Existing Credit Agreement with new revolving commitments under the Credit Agreement in an aggregate principal amount of $630 million (the "New Revolving Facility" and, together with the New Term Loans, the "Credit Facilities"). The maturity date of the New Revolving Facility is January 30, 2030. The New Revolving Facility, when drawn, will bear interest at a rate equal to the applicable benchmark plus an applicable margin that varies based on the Company's leverage ratio. The applicable margin for revolving borrowings ranges from 2.25% to 1.75% per annum in the case of Term Benchmark Loans and 1.25% to 0.75% per annum in the case of ABR Loans. In addition to paying interest on outstanding borrowings under the New Revolving Facility, the Company must also pay a quarterly commitment fee based on the average daily unused portion of the New Revolving Facility during such quarter, which is determined by its leverage ratio and ranges from 0.25% to 0.50% per annum.

The Credit Agreement contains certain affirmative and negative covenants customary for financings of this type. The Credit Agreement also contains certain customary events of default. The New Revolving Facility is subject to a financial covenant requiring the maintenance of a consolidated total leverage ratio of not greater than 4.7 to 1.00 as of the end of each fiscal quarter if, on the last day of any such fiscal quarter, the aggregate amount of loans and letters of credit (excluding backstopped or cash collateralized letters of credit and other letters of credit with an aggregate face amount not exceeding $30 million) outstanding under the New Revolving Facility exceeds 35% of the aggregate commitments in effect thereunder on such date. The Credit Facilities are secured on a first-priority basis by: (1) a perfected security interest in the equity interests of each direct material subsidiary of each guarantor under the Credit Facilities and (ii) perfected security interests in, and mortgages on, substantially all tangible and intangible personal property and material real property of each of the guarantors under the Credit Facilities, subject, in each case, to certain exceptions and limitations, including the agreed guaranty and security principles.

As of September 30, 2025, the Company was in compliance with all covenants under the 2032 Senior Notes indenture and Credit Agreement.

The principal outstanding and carrying amounts of our long-term debt as of September 30, 2025 and December 31, 2024 are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Due** | **Interest Rate** | **September 30,<br>2025** | **December 31,<br>2024** |
| 2021 Dollar Term Facility | 4/30/2028 | SOFR plus 275 bps  | $— | $692 |
| 2025 Dollar Term Facility | 1/30/2032 | SOFR plus 200 bps | 688 |  |
| 2032 Senior Notes | 5/31/2032 | 7.75% | 800 | 800 |
| Other |  |  | 2 | 1 |
| Total principal outstanding |  |  | 1490 | 1493 |
| Less: unamortized deferred financing costs |  |  | (23) | (22) |
| Less: current portion of long-term debt |  |  | (7) | (7) |
| Total long-term debt |  |  | $1460 | $1464 |

---

Separate from the New Revolving Facility, the Company has a bilateral letter of credit facility with outstanding letters of credit in the amount of $9 million and $8 million at September 30, 2025 and December 31, 2024, respectively. The letters of credit typically support customs arrangements and other obligations at our local affiliates.

Minimum scheduled principal repayments of long-term debt as of September 30, 2025 are as follow:

------

---

| | |
|:---|:---|
| | **September 30,<br>2025** |
| | **(Dollars in millions)** |
| 2025 | $1 |
| 2026 | 7 |
| 2027 | 7 |
| 2028 | 9 |
| 2029 | 7 |
| Thereafter | 1459 |
| Total debt payments | $1490 |

---

**Note 15. Equity**

***Common Stock***

On December 5, 2024, the Board of Directors declared a cash dividend of $0.06 per share of Common Stock, payable on January 31, 2025, to shareholders of record as of January 15, 2025. The total amount of dividends paid on January 31, 2025 amounted to $12 million.

On May 1, 2025, the Board of Directors declared a cash dividend of $0.06 per share of Common Stock, payable on June 16, 2025, to shareholders of record as of June 2, 2025. The total amount of dividends paid on June 16, 2025 amounted to $13 million.

On July 24, 2025, the Board of Directors declared a cash dividend of $0.06 per share of Common Stock, payable on September 16, 2025, to shareholders of record as of September 2, 2025. The total amount of dividends paid on September 16, 2025 amounted to $11 million.

***Treasury Stock***

Treasury stock represents shares of the Company's Common Stock that have been issued and subsequently repurchased by the Company or withheld to satisfy withholding tax obligations in connection with the vesting of equity awards, and that have not been retired or cancelled. The Company accounts for treasury stock under the cost method and includes treasury stock as a component of Equity (Deficit) on the Consolidated Interim Balance Sheet. The Company accounts for the reissuance of treasury stock using the average cost method. The Company did not reissue or retire any shares of treasury stock during the three and nine months ended September 30, 2025.

***Share Repurchase Program***

On December 4, 2024, the Board of Directors authorized a $250 million share repurchase program valid January 1, 2025 until December 31, 2025. The Company may repurchase shares from time to time under the program through various methods, including in open market transactions, block trades, privately negotiated transactions, and otherwise. The timing, as well as the number and value of shares repurchased under the program, will depend on a variety of factors. The Company is not obligated to purchase any shares under the repurchase program, and the program may be suspended, modified, or discontinued at any time without prior notice. During the nine months ended September 30, 2025, the Company repurchased $136 million of Common Stock, and had $114 million remaining under the share repurchase program as of that date. These repurchases include a total of 5 million shares repurchased from funds affiliated with Oaktree Capital Management, L.P., a related party, for approximately $62 million. The repurchased shares are held as treasury stock.

**Note 16. Financial Instruments and Fair Value Measures**

Our credit, market, and foreign currency risk management policies are described in Note 19, *Financial Instruments and Fair Value Measures*, to the Consolidated Financial Statements for the year ended December 31, 2024 included in our 2024 Form 10-K. As of September 30, 2025 and December 31, 2024, we had contracts with aggregate gross notional amounts of $889 million and $928 million, respectively, to hedge foreign currencies, principally the U.S. Dollar, Swiss Franc, British Pound, Euro, Chinese Yuan, Japanese Yen, Mexican Peso, New Romanian Leu, Czech Koruna, Australian Dollar, and Korean Won.

------

***Fair Value of Financial Instruments***

The FASB's accounting guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). Financial and nonfinancial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The following table sets forth the Company's financial assets and liabilities that were accounted for at fair value on a recurring basis as of September 30, 2025 and December 31, 2024:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | | **Fair Value** | **Fair Value** | **Fair Value** | **Fair Value** | **Fair Value** | **Fair Value** |
| | **Notional Amounts** | **Notional Amounts** | **Assets** | **Assets** | | **Liabilities** | **Liabilities** | |
| | **September 30,<br>2025** | **December 31, 2024** | **September 30,<br>2025** | **December 31, 2024** | | **September 30,<br>2025** | **December 31, 2024** | |
| *Designated instruments:* |  |  |  |  |  |  |  |  |
| Designated forward currency exchange contracts | $465 | $331 | $13 | $4 | (a) | $8 | $6 | (c) |
| Designated cross-currency swaps | 2040 | 1515 | 2 | 82 | (b) | 170 |  | (d) |
| Designated interest-rate swaps | 675 |  |  |  | (b) | 17 |  | (d) |
| Total designated instruments | 3180 | 1846 | 15 | 86 |  | 195 | 6 |  |
| *Undesignated instruments:* |  |  |  |  |  |  |  |  |
| Undesignated interest rate swaps |  | 470 |  | 9 | (b) |  | 3 | (d) |
| Undesignated forward currency exchange contracts | 424 | 597 | 1 | 9 | (a) | 2 | 2 | (c) |
| Total undesignated instruments | 424 | 1067 | 1 | 18 |  | 2 | 5 |  |
| Total designated and undesignated instruments | $3604 | $2913 | $16 | $104 |  | $197 | $11 |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Recorded within Other current assets

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Recorded within Other assets

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Recorded within Accrued liabilities

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Recorded within Other liabilities

***Cash Flow Hedges***

During 2023, the Company entered into float-to-fixed interest rate swap contracts with an aggregate notional amount of $200 million and maturities in July 2024 and October 2024. The Company also entered into a float-to-fixed cross-currency swap contract comprised of an amortizing swap with an aggregate notional amount of €280 million ($300 million) and notional exchanges in June 2026, June 2027, and June 2028. The interest rate swap and cross-currency swap contracts were early settled in the second quarter of 2024, resulting in net gains of $18 million recorded to Interest expense and a $4 million loss recorded to Non-operating expense in the Consolidated Interim Statement of Operations.

During 2025, the Company entered into float-to-fixed interest rate swap contracts with an aggregate notional amount of $675 million and maturities in January 2027, January 2028, January 2029, January 2030 and January 2031. Changes in the fair value of the interest rate swap contracts are recorded in Accumulated Other Comprehensive Income ("AOCI") and will be reclassified to Interest expense in the Consolidated Interim Statement of Operations upon maturity.

The Company also has outstanding forward currency exchange contracts with maturities up to 18 months and an aggregate notional amount of $465 million and $331 million as of September 30, 2025 and December 31, 2024, respectively. These forward currency exchange contracts have been designated as cash flow hedges to mitigate foreign currency exposures primarily on our inventory purchases and manufacturing costs. The gains and losses on the forward currency exchange contracts are recorded in AOCI and reclassified to Cost of goods sold in the Consolidated Interim Statement of Operations when the underlying transactions are recognized in earnings.

In order to mitigate foreign currency risk on its 2032 Senior Notes, the Company entered into fixed-to-fixed cross-currency swap contracts with an aggregate notional amount of €507 million ($550 million) and notional exchanges occurring in May 2027, May 2028, May 2029, and May 2030. Changes in the fair value of the cross-currency swap contracts are recognized in AOCI and reclassified to Non-operating (income) expense in the Consolidated Interim

------

Statement of Operations, based upon changes in the spot rate remeasurement of the underlying debt. The net interest settlements on the cross-currency swap contracts are recorded in Interest expense in the Consolidated Interim Statements of Operations.

All of the Company's cash flow hedges are assessed as highly effective.

***Net Investment Hedges***

The Company has designated cross-currency swaps with aggregate notional amounts of €1,381 million ($1,490 million) and €858 million ($965 million) as of September 30, 2025 and December 31, 2024, respectively, as net investment hedges of its Euro-denominated operations. Changes in the fair value of the net investment hedges are recorded in AOCI until the net investment is liquidated or sold. The fair values of the net investment hedges were a net liability of $122 million and a net asset of $70 million as of September 30, 2025 and December 31, 2024, respectively. No ineffectiveness has been recorded on the net investment hedges.

***Non-Designated Derivatives***

As of December 31, 2024, the Company had outstanding float-to-fixed interest rate swap contracts with an aggregate notional amount of €450 million ($470 million) and maturities of April 2025, April 2026, April 2027, and April 2028. Changes in the fair value of the undesignated interest rate swap contracts are recorded in Interest expense in the Consolidated Interim Statements of Operations. These interest rate swap contracts were early settled in 2025.

The Company also has outstanding forward currency exchange contracts with maturities generally up to 3 months and an aggregate notional amount of $424 million and $597 million as of September 30, 2025 and December 31, 2024, respectively. Changes in the fair value of the forward currency exchange contracts are recorded in Non-operating (income) expense in the Consolidated Interim Statements of Operations.

***Effect of Derivatives on the Statements of Operations and Statements of Comprehensive Income (Loss)***

The following tables present the pretax impact that changes in the fair values of derivatives designated as cash flow hedges and net investment hedges had on OCI, AOCI and earnings:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **Cash flow hedges** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain (loss) reclassified from AOCI to <br> income: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Cost of goods sold | $(1) | $1 | $(1) | $(3) |
| &nbsp;&nbsp;&nbsp;&nbsp; Interest expense <sup>(1)</sup> |  | 1 | (4) |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Non-operating income <sup>(2)</sup>  | 1 | 23 | 65 | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain (loss) recognized in other comprehensive <br> income (loss) | 6 | (1) | (3) | 1 |
| **Net investment hedges** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain (loss) recognized in other comprehensive <br> income (loss) | 6 | (35) | (171) | (2) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Includes a settlement loss of $3 million for the nine months ended September 30, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Includes a settlement loss of $4 million for the nine months ended September 30, 2024.

The following table summarizes the pretax gain (loss) that changes in the fair values of derivatives not designated as hedging instruments had on earnings:

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | | **2025** | **2024** | **2025** | **2024** |
| Contract Type | Location | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Interest rate swaps | Interest expense <sup>(1)</sup>  | $— | $(4) | $— | $9 |
| Forward currency exchange contracts | Non-operating income | (1) | (5) | (27) | 8 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Includes interest income of $5 million, partially offset by marked-to-market remeasurement losses of $9 million, for the three months ended September 30, 2024. Includes settlement gain of $21 million and interest income of $21 million, partially offset by marked-to-market remeasurement losses of $33 million, for the nine months ended September 30, 2024.

***Fair Value Measurement***

The foreign currency exchange, interest rate swap and cross-currency swap contracts are valued using market observable inputs. As such, these derivative instruments are classified within Level 2. The assumptions used in measuring the fair value of the cross-currency swap are considered Level 2 inputs, which are based upon market-observable interest rate curves, cross-currency basis curves, credit default swap curves, and foreign exchange rates.

The carrying value of Cash, cash equivalents, and restricted cash, Account receivables and Notes and Other receivables contained in the Consolidated Interim Balance Sheet approximates fair value.

The following table sets forth the Company's financial assets and liabilities that were not carried at fair value:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| | **Carrying Value** | **Fair Value** | **Carrying Value** | **Fair Value** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Term Loan Facilities | $675 | $687 | $680 | $693 |
| &nbsp;&nbsp;&nbsp;&nbsp;2032 Senior Notes | 790 | 839 | 790 | 810 |

---

The Company determined the fair value of its Term Loan Facilities and related current maturities utilizing transactions in the listed markets for similar liabilities. As such, the fair value of the Term Loan Facilities and related current maturities is considered Level 2. The fair value of the 2032 Senior Notes was determined using quoted prices from exchange traded markets and is classified as a Level 1 measurement.

**Note 17. Accumulated Other Comprehensive Income**

The changes in AOCI by component are set forth below:

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **Foreign Exchange Translation Adjustment** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning of period | $(115) | $(39) | $(27) | $(57) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive (loss) income before <br>&nbsp;&nbsp;&nbsp;&nbsp; reclassifications | 3 | (30) | (85) | (7) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax benefit (expense) associated with <br>&nbsp;&nbsp;&nbsp;&nbsp;comprehensive income (loss) before reclassifications |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amounts reclassified from AOCI |  |  |  | (5) |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at end of period | (112) | (69) | (112) | (69) |
| **Pension Adjustments** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning of period | (15) | (17) | (15) | (20) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) before <br>&nbsp;&nbsp;&nbsp;&nbsp;reclassifications |  | 1 |  | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax benefit (expense) associated with <br>&nbsp;&nbsp;&nbsp;&nbsp;comprehensive income (loss) before reclassifications |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at end of period | (15) | (16) | (15) | (16) |
| **Changes in Fair Value of Effective Cash Flow Hedges** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning of period | 9 | (1) | (10) | (2) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive (loss) income before <br>&nbsp;&nbsp;&nbsp;&nbsp; reclassifications | 5 | (33) | 51 | (9) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax benefit (expense) associated with <br>&nbsp;&nbsp;&nbsp;&nbsp;comprehensive income (loss) before reclassifications |  | 14 | 26 | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amounts reclassified from AOCI |  | 25 | (60) | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes associated with reclassifications from AOCI |  | (2) | 7 | (1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at end of period | 14 | 3 | 14 | 3 |
| **Changes in Fair Value of Net Investment Hedges** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning of period | (38) | 103 | 125 | 76 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive (loss) income before <br>&nbsp;&nbsp;&nbsp;&nbsp; reclassifications | 6 | (35) | (171) | (2) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax benefit (expense) associated with <br>&nbsp;&nbsp;&nbsp;&nbsp;comprehensive income (loss) before reclassifications | (1) | 4 | 13 | (2) |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at end of period | (33) | 72 | (33) | 72 |
| Accumulated other comprehensive (loss) income, end of <br> period | $(146) | $(10) | $(146) | $(10) |

---

------

Reclassifications from AOCI to income were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **Foreign Exchange Translation Adjustment** |  |  |  |  |
| Reclassification adjustments recognized in income <sup>(1)</sup>  | $— | $— | $— | $(5) |
| &nbsp;&nbsp;&nbsp;&nbsp; Amounts reclassified from AOCI |  |  |  | (5) |
| **Changes in Fair Value of Effective Cash Flow Hedges** |  |  |  |  |
| Reclassification forward currency exchange contracts to <br> Cost of goods sold | $1 | $1 | $1 | $(3) |
| Reclassification cross-currency swaps to Interest expense |  | 1 | 4 |  |
| Reclassification cross-currency swaps to Non-operating <br> (income) expense | (1) | 23 | (65) | 10 |
| Tax effect on reclassification to income |  | (2) | 7 | (1) |
| &nbsp;&nbsp;&nbsp;&nbsp; Amounts reclassified from AOCI, net |  | 23 | (53) | 6 |
| Total reclassifications for the period | $— | $23 | $(53) | $1 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(1) Cumulative translation losses reclassified to Net income related to the sale of an equity interest in an unconsolidated joint venture. See Note 22 for discussion.* 

**Note 18. Earnings Per Share**

Basic earnings per share ("EPS") is computed using the weighted-average number of common shares outstanding during the period.

Diluted earnings per share is calculated based on the weighted-average number of common shares outstanding for the period plus the dilutive effect of common stock equivalents using the treasury stock method.

The details of the EPS calculations for the three and nine months ended September 30, 2025 and 2024 are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions except per share)** | **(Dollars in millions except per share)** | **(Dollars in millions except per share)** | **(Dollars in millions except per share)** |
| **Basic earnings per share:** |  |  |  |  |
| Net income | $77 | $52 | $226 | $182 |
| Weighted average common shares outstanding – Basic | 198668143 | 217283749 | 202127953 | 226057803 |
| EPS – Basic | $0.39 | $0.24 | $1.12 | $0.80 |
| **Diluted earnings per share:** |  |  |  |  |
| Weighted average common shares outstanding – Basic | 198668143 | 217283749 | 202127953 | 226057803 |
| Dilutive effect of unvested RSUs and other contingently issuable shares | 3526191 | 1119932 | 3002663 | 1591944 |
| Weighted average common shares outstanding – Diluted | 202194334 | 218403681 | 205130616 | 227649747 |
| EPS – Diluted | $0.38 | $0.24 | $1.10 | $0.80 |

---

------

**Note 19. Commitments and Contingencies**

We are involved in various lawsuits, claims, and proceedings incident to the operation of our businesses, including those pertaining to product liability, product safety, environmental, health and safety, intellectual property, employment, commercial and contractual matters and various other matters. We regularly assess the likelihood of adverse judgments or outcomes in these matters, as well as potential ranges of possible losses based on a careful analysis of each matter. We identify below the individual proceedings where we believe a material loss is reasonably possible or probable, and we accrue for matters when we believe that losses are probable and the amount of the potential loss is reasonably estimable. It is inherently difficult to determine whether a loss is probable or reasonably possible or to estimate the size or range of any potential loss. Accordingly, while we believe that appropriate accruals have been established for losses that are probable and can be reasonably estimated, it is possible that adverse outcomes from such proceedings could exceed the amounts accrued by an amount that could be material to our financial position, results of operations or cash flows.

***Brazilian Tax Matter***

In September 2020, the Brazilian tax authorities issued an infraction notice against Garrett Motion Industria Automotiva Brasil Ltda, challenging the use of certain tax credits between January 2017 and February 2020. The estimated total amount of the loss contingency arising from this matter as of September 30, 2025 was $26 million, including penalties and interest. The Company believes, based on management's assessment and the advice of external legal counsel, that it has meritorious arguments in connection with the infraction notice and any liability for the infraction notice is currently not probable. Accordingly, no accrual is required at this time.

***Warranties and Guarantees***

In the normal course of business, we issue product warranties and product performance guarantees. We accrue for the estimated cost of product warranties and performance guarantees based on contract terms and historical experience at the time of sale to the customer. Adjustments to initial obligations for warranties and guarantees are made as changes to the obligations become reasonably estimable. Product warranties and product performance guarantees are included in Accrued liabilities and Other liabilities. The following table summarizes information concerning our recorded obligations for product warranties and product performance guarantees.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Warranty and product performance guarantees at beginning of period | $23 | $25 | $23 | $27 |
| Accruals for warranties/guarantees issued during the period | 5 | 3 | 11 | 8 |
| Settlement of warranty/guarantee claims | (7) | (4) | (15) | (10) |
| Foreign currency translation |  | 1 | 2 |  |
| Warranty and product performance guarantees at end of period | $21 | $25 | $21 | $25 |

---

***Other Commitments and Contingencies***

We are subject to other lawsuits, investigations, and disputes arising out of the conduct of our business, including matters relating to commercial transactions, government contracts, product liability, prior acquisitions and divestitures, employment and employee benefit plans, intellectual property, and environmental, health and safety matters. We recognize a liability for any contingency that is probable of occurring and reasonably estimable. We regularly assess the likelihood of adverse judgments or outcomes in these matters, as well as potential ranges of possible losses (taking into consideration any insurance recoveries), based on a careful analysis of each matter with the assistance of outside legal counsel and, if applicable, other experts.

**Note 20. Pension Benefits**

We sponsor several funded U.S. and non-U.S. defined benefit pension plans. Significant plans outside the U.S. are in Switzerland and Ireland. Other pension plans outside the U.S. are not material to the Company, either individually or in the aggregate.

------

Our general funding policy for qualified defined benefit pension plans is to contribute amounts at least sufficient to satisfy regulatory funding standards. We are not required to make any contributions to our U.S. pension plan in 2025. We expect to make contributions of cash and/or marketable securities of approximately $5 million to our non-U.S. pension plans to satisfy regulatory funding standards in 2025, of which $5 million has been contributed as of September 30, 2025.

Net periodic benefit costs for our significant defined benefit plans include the following components:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **U.S. Plans** | **U.S. Plans** | **Non-U.S. Plan** | **Non-U.S. Plan** | **U.S. Plans** | **U.S. Plans** | **Non-U.S. Plan** | **Non-U.S. Plan** |
| | **2025** | **2024** | **2025** | **2024** | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Service cost | $— | $— | $2 | $2 | $— | $— | $5 | $5 |
| Interest cost | 2 | 2 | 1 | 1 | 6 | 6 | 3 | 3 |
| Expected return on plan assets | (2) | (2) | (2) | (2) | (6) | (6) | (5) | (6) |
| Amortization of prior service (credit) |  |  |  |  |  |  | (1) | (1) |
| Total | $— | $— | $1 | $1 | $— | $— | $2 | $1 |

---

For both our U.S. and non-U.S. defined benefit pension plans, we estimate the service and interest cost components of net periodic benefit (income) cost by utilizing a full yield curve approach in the estimation of these cost components by applying the specific spot rates along the yield curve used in the determination of the pension benefit obligation to their underlying projected cash flows. This approach provides a more precise measurement of service and interest costs by improving the correlation between projected cash flows and their corresponding spot rates.

**Note 21. Segments and Concentrations**

The Company has identified our CODM as the Chief Executive Officer. The CODM reviews consolidated net income when assessing the Company's performance, allocating resources, and establishing management's compensation. In addition to consolidated net income, the CODM receives discrete information for net sales by product and by geographical location. Consolidated net income is used to monitor budget versus actual results.

The accounting policies of our operating segment are the same as those described in the Company's summary of significant accounting policies.

The Company derives revenues from customers through sales of air and fluid compression and high-speed electric motor technologies for OEMs and distributors within the mobility and industrial space. In addition to consolidated net income, the CODM regularly reviews sales by region and product line.

**Sales concentration** - Net sales by region (determined based on country of shipment) and product line are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| United States | $170 | $178 | $524 | $530 |
| Europe |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Germany | 96 | 76 | 271 | 250 |
| &nbsp;&nbsp;&nbsp;&nbsp; Rest of Europe | 338 | 300 | 1049 | 1029 |
| Asia |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; China | 167 | 144 | 471 | 464 |
| &nbsp;&nbsp;&nbsp;&nbsp; Rest of Asia | 97 | 108 | 300 | 303 |
| Other International | 34 | 20 | 78 | 55 |
|  | $902 | $826 | $2693 | $2631 |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Diesel | $201 | $180 | $626 | $641 |
| Gas | 405 | 360 | 1206 | 1123 |
| Commercial Vehicle | 164 | 155 | 489 | 477 |
| Aftermarket | 116 | 117 | 325 | 350 |
| Other | 16 | 14 | 47 | 40 |
|  | $902 | $826 | $2693 | $2631 |

---

The table below provides segment information about the Company:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Net sales | $902 | $826 | $2693 | $2631 |
| Less: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Material costs | 500 | 478 | 1514 | 1533 |
| &nbsp;&nbsp;&nbsp;&nbsp;Variable manufacturing costs <sup>(1)</sup> | 121 | 87 | 342 | 279 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed manufacturing costs <sup>(2)</sup> | 62 | 52 | 173 | 168 |
| &nbsp;&nbsp;&nbsp;&nbsp;RD&E costs | 33 | 43 | 118 | 128 |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative costs | 57 | 53 | 175 | 178 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 29 | 37 | 83 | 130 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense | 25 | 24 | 63 | 62 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other segment items <sup>(3)</sup> | (2) |  | (1) | (29) |
| Consolidated net income | $77 | $52 | $226 | $182 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Variable manufacturing costs include freight, duties and tariffs, direct and indirect labor costs, repairs and maintenance, and variable overhead costs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Fixed manufacturing costs include depreciation and amortization, rent, overhead labor costs, repositioning costs, utilities and other fixed costs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Other segment items consist of gain on sale of equity interest in unconsolidated joint venture, non-service components of net periodic pension expense, interest income, equity income and other non-operating income items (if any).

The measure of segment assets is reported on the balance sheet as total consolidated assets. The Company had capital expenditures of $10 million and $20 million for the three months ended September 30, 2025 and 2024, respectively, and $51 million and $69 million for the nine months ended September 30, 2025 and 2024, respectively.

**Note 22. Acquisitions and Divestitures**

On April 3, 2024, the Company divested its equity interest in an unconsolidated joint venture for approximately $58 million, subject to customary debt and working capital adjustments. We received cash consideration on the divestiture date of $46 million. An additional $7 million of deferred payments is to be received in equal installments due twelve months and thirty-six months from the divestiture date, with the first deferred payment received in 2025. A pre-tax gain of $27 million was recognized related to this divestiture, including $5 million of cumulative translation losses reclassified from AOCI to Net income. Transaction fees of $1 million were incurred in connection with the divestiture and are included in Selling, general, and administrative expenses in our Consolidated Interim Statement of Operations.

------

**Note 23. Subsequent Events**

On October 23, 2025, the Company made a voluntary early debt repayment of $50 million on its 2025 Dollar Term Facility.

Also on October 23, 2025, the Board of Directors declared a cash dividend of $0.08 per share of Common Stock, payable on December 15, 2025, to shareholders of record as of December 1, 2025.

------

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations** 

*The following discussion and analysis of our financial condition and results of operations, which we refer to as our "MD&A," should be read in conjunction with our Consolidated Interim Financial Statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q as well as the audited annual Consolidated Financial Statements for the year ended December 31, 2024, included in our 2024 Form 10-K. Some of the information contained in this MD&A or set forth elsewhere in this Quarterly Report on Form 10-Q, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve various risks and uncertainties. Please refer to the "Special Note Regarding Forward-Looking Statements" below.* 

The following MD&A is intended to help you understand the results of operations and financial condition of Garrett Motion Inc. for the three and nine months ended September 30, 2025.

**Executive Summary**

During the third quarter of 2025, we continued to navigate macro-economic challenges. Increased demand in light vehicle gasoline, primarily driven by new program launches in Europe, China, India and North America, was partially offset by decreased demand for Aftermarket off-highway replacement parts in North America, resulting in unfavorable product mix. Driven by sustainable cost initiatives implemented over the last year and the current year, successful recovery of import tariffs, and a favorable foreign exchange environment, we delivered Net income of $77 million and Adjusted EBIT of $133 million for the quarter.

We continue to have success across our differentiated technologies by winning business in both turbo and zero emission offerings. We secured light vehicle turbo awards in the US, India and Brazil and continued to win commercial vehicle and industrial business across multiple regions, including turbo technology for data centers. With respect to our zero-emission offerings, we deepened our strategic collaborations with OEMs by executing additional E-Powertrain proof-of-concept initiatives. Furthermore, we received favorable feedback related to the efficiency gains for our E-Cooling oil-free compressor from mobility and industrial customers. These zero-emission technologies lay the foundation for future business growth.

For the three months ended September 30, 2025, we repurchased $84 million of Common Stock under our share repurchase program. These repurchases include a total of 5 million shares from funds affiliated with Oaktree Capital Management, L.P., a related party, for approximately $62 million. As of September 30, 2025, we had $114 million of the authorized amount remaining under our share repurchase program. The repurchased shares are held as treasury stock.

On July 24, 2025, the Board of Directors declared a cash dividend of $0.06 per share of Common Stock, payable on September 16, 2025, to shareholders of record as of September 2, 2025. The total amount of dividends paid on September 16, 2025 amounted to $11 million.

**Disaggregated Revenue** 

The following tables show our revenues by geographic region and product line for the three and nine months ended September 30, 2025 and 2024, respectively.

***By Region***

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2025** | **2024** | **2024** | **2025** | **2025** | **2024** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| United States | $170 | 19% | $178 | 22% | $524 | 19% | $530 | 20% |
| Europe | 434 | 48% | 376 | 46% | 1320 | 49% | 1279 | 49% |
| Asia | 264 | 29% | 252 | 30% | 771 | 29% | 767 | 29% |
| Other | 34 | 4% | 20 | 2% | 78 | 3% | 55 | 2% |
| Total | $902 |  | $826 |  | $2693 |  | $2631 |  |

---

------

***By Product Line***

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2025** | **2024** | **2024** | **2025** | **2025** | **2024** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Diesel | $201 | 22% | $180 | 22% | $626 | 23% | $641 | 24% |
| Gas | 405 | 45% | 360 | 43% | 1206 | 45% | 1123 | 43% |
| Commercial Vehicle | 164 | 18% | 155 | 19% | 489 | 18% | 477 | 18% |
| Aftermarket | 116 | 13% | 117 | 14% | 325 | 12% | 350 | 13% |
| Other | 16 | 2% | 14 | 2% | 47 | 2% | 40 | 2% |
| Total | $902 |  | $826 |  | $2693 |  | $2631 |  |

---

**Results of Operations for the Three and Nine Months Ended September 30, 2025** 

***Net Sales***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Net sales | $902 | $826 | $2693 | $2631 |
| % change compared with prior period | 9.2% |  | 2.4% |  |

---

***Net Sales for the Three Months Ended September 30, 2025***

![Q3 2025 Sales Walk.jpg](gtx-20250930_g1.jpg)

For the three months ended September 30, 2025, net sales compared to the prior period increased by $76 million or 9% (including a favorable impact of $26 million or 3% due to foreign currency translation primarily driven by higher Euro-to-U.S. dollar exchange rates). This increase was primarily related to favorable foreign currency impacts and higher demand in gasoline and diesel, partially offset by weaker demand for replacement parts on aftermarket sales and unfavorable product mix. Net sales also includes $12 million of recoveries on enacted import tariffs.

Gasoline product sales increased by $45 million or 13% (including a favorable impact of $11 million or 3% due to foreign currency translation), primarily driven by new application launches and program ramp-ups in Europe, China, India and North America.

Diesel product sales increased by $21 million or 12% (including a favorable impact of $9 million or 5% due to foreign currency translation), primarily driven by strong light commercial vehicle performance in Europe combined with sustained demand for pickup trucks in North America, South America and Southeast Asia.

Commercial vehicle sales increased by $9 million or 6% (including a favorable impact of $2 million or 2% due to foreign currency translation), primarily driven by launch of an on-highway program in Europe and partial recovery of prior year softness in the construction and agriculture industries.

Aftermarket sales decreased by $1 million or 1% (including a favorable impact of $3 million or 3% due to foreign currency translation), primarily due to softer demand for off-highway replacement parts in North America.

------

***Net Sales for the Nine Months Ended September 30, 2025***

![Q3 2025 YTD Sales Walk.jpg](gtx-20250930_g2.jpg)

For the nine months ended September 30, 2025, net sales compared to the prior period increased by $62 million or 2% (including a favorable impact of $28 million or 1% due to foreign currency translation, primarily driven by fluctuations in global exchange rates). This increase was primarily related to favorable foreign currency impacts and higher demand in gasoline and commercial vehicles, partially offset by weaker demand for replacement parts on aftermarket sales and weakness in light vehicle diesel in Europe. Net sales also include $30 million of recoveries on enacted import tariffs.

Gasoline product sales increased by $83 million or 7% (including a favorable impact of $10 million or 1% due to foreign currency translation), primarily driven by new application launches and program ramp-ups in Europe, North America and India.

Diesel product sales decreased by $15 million or 2% (including a favorable impact of $11 million or 2% due to foreign currency translation), primarily driven by passenger vehicles in Europe pursuing transition to gasoline hybrids, partially offset by sustained demand for pickup trucks in North America, South America and Southeast Asia.

Commercial vehicle sales increased by $12 million or 3% (including a favorable impact of $3 million or 1% due to foreign currency translation), primarily driven by launch of an on-highway program in Europe and partial recovery of prior year softness in the construction and agriculture industries.

Aftermarket sales decreased by $25 million or 7% (including a favorable impact of $3 million or 1% due to foreign currency translation), primarily driven by softer demand for off-highway replacement parts in North America.

***Cost of Goods Sold and Gross Profit***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Cost of goods sold | $716 | $660 | $2147 | $2108 |
| % change compared with prior period | 8.5% |  | 1.9% |  |
| Gross profit percentage | 20.6% | 20.1% | 20.3% | 19.9% |

---

------

***Cost of Goods Sold and Gross Profit for the Three Months Ended September 30, 2025***

---

| | | |
|:---|:---|:---|
| | **Cost of Goods Sold** | **Gross Profit** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Cost of Goods Sold / Gross Profit for the three months ended September 30, 2024 | $660 | $166 |
| *Increase/(decrease) due to:* |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Volume | 61 | 28 |
| &nbsp;&nbsp;&nbsp;&nbsp;Product mix | (9) | (28) |
| &nbsp;&nbsp;&nbsp;&nbsp;Price, net of inflation pass-through |  | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;Commodity, transportation & energy inflation | (7) | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Productivity, net | (6) | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;Enacted import tariffs | 12 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Research & development | (6) | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange rate impacts | 11 | 14 |
| Cost of Goods Sold / Gross Profit for the three months ended September 30, 2025 | $716 | $186 |

---

For the three months ended September 30, 2025, cost of goods sold increased by $56 million, primarily driven by $61 million from higher sales volumes, $12 million from enacted import tariffs and $11 million from foreign currency impacts. These increases were partially offset by $9 million of favorable product mix, $7 million of commodity, transportation and energy deflation, $6 million of productivity net of labor inflation and $6 million of lower R&D costs.

For the three months ended September 30, 2025, gross profit increased by $20 million, primarily driven by $28 million from higher sales volumes, $14 million from foreign currency impacts, $10 million from productivity net of labor inflation, $7 million from commodity, transportation and energy deflation and $6 million of lower R&D costs. These increases were partially offset by $28 million of unfavorable product mix and $17 million of pricing, net of inflation pass-through.

***Cost of Goods Sold and Gross Profit for the Nine Months Ended September 30, 2025***

---

| | | |
|:---|:---|:---|
| | **Cost of Goods Sold** | **Gross Profit** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Cost of Goods Sold / Gross Profit for the nine months ended September 30, 2024 | $2108 | $523 |
| *Increase/(decrease) due to:* |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Volume | 52 | 22 |
| &nbsp;&nbsp;&nbsp;&nbsp;Product mix | 1 | (60) |
| &nbsp;&nbsp;&nbsp;&nbsp;Price, net of inflation pass-through |  | (15) |
| &nbsp;&nbsp;&nbsp;&nbsp;Commodity, transportation & energy inflation | (20) | 20 |
| &nbsp;&nbsp;&nbsp;&nbsp;Productivity, net | (30) | 35 |
| &nbsp;&nbsp;&nbsp;&nbsp;Enacted import tariffs | 31 | (1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Research & development | (7) | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange rate impacts | 12 | 15 |
| Cost of Goods Sold / Gross Profit for the nine months ended September 30, 2025 | $2147 | $546 |

---

For the nine months ended September 30, 2025, cost of goods sold increased by $39 million, primarily driven by $52 million from higher sales volumes, $31 million from enacted import tariffs, $12 million from foreign currency impacts and $1 million from unfavorable product mix. These increases were partially offset by $30 million of productivity net of labor inflation, $20 million of commodity, transportation and energy deflation and $7 million of lower R&D costs.

For the nine months ended September 30, 2025, gross profit increased by $23 million, primarily driven by $35 million of productivity, net of labor inflation, $22 million of higher sales volumes, $20 million of commodity, transportation and energy deflation, $15 million from foreign currency impacts and $7 million of lower R&D costs. These increases were

------

partially offset by $60 million from unfavorable product mix and $15 million of price net of inflation pass through. We also had a $1 million impact to gross profit from newly enacted import tariffs due to the timing of negotiated recoveries.

***Selling, General and Administrative Expenses*** 

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Selling, general and administrative expense | $57 | $53 | $175 | $178 |
| % of sales | 6.3% | 6.4% | 6.5% | 6.8% |

---

Selling, general and administrative ("SG&A") expenses for the three months ended September 30, 2025, increased by $4 million compared with the prior period, primarily driven by $4 million unfavorable foreign currency impacts and $2 million of higher bad debt expense. These increases were partially offset by a $3 million reduction in personnel costs, driven by sustainable cost measures implemented in the current and prior years.

SG&A expenses for the nine months ended September 30, 2025, decreased by $3 million compared with the prior period, primarily driven by a $5 million reduction in personnel costs related to cost measures implemented in current and prior years and $3 million of lower outsourced activities partially offset by $6 million primarily related to acquisition and divestiture expenses.

***Other Expense, Net***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | | | **(Dollars in millions)** | **(Dollars in millions)** |
| Other expense, net | $1 | $1 | $9 | $5 |

---

Other expense, net for the three months ended September 30, 2025 was consistent with the prior period.

Other expense, net for the nine months ended September 30, 2025 increased by $4 million compared to the prior period, primarily driven by $6 million in third-party costs related to our Restatement Agreement partially offset by $2 million of professional fees associated with our 2032 Senior Notes in the prior year.

***Interest Expense***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Interest expense | $29 | $37 | $83 | $130 |

---

For the three months ended September 30, 2025, interest expense decreased by $8 million compared to the prior period. This decrease was primarily due to $3 million in lower interest expense resulting from the Amendment and Restatement of our Credit Agreement. Additionally, we did not record any net gains on designated and undesignated interest rate derivatives in the current year, in comparison to net gains of $5 million in the prior year.

For the nine months ended September 30, 2025, interest expense decreased by $47 million compared to the prior period. This decrease was primarily due to a $30 million reduction in debt issuance cost amortization, driven by accelerated amortization in the prior year, and $22 million of lower interest expense resulting from the Amendment and Restatement of our Credit Agreement. In addition, we recorded net gains of $4 million on our designated and undesignated interest derivatives in the current year, in comparison to net gains of $9 million in the prior year.

***Non-Operating Income, Net***

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Non-operating income, net | $(3) | $(1) | $(10) | $(7) |

---

For the three months ended September 30, 2025, we had non-operating income of $3 million versus $1 million in the prior period. The increase in non-operating income was primarily driven by higher interest income.

For the nine months ended September 30, 2025, we had non-operating income of $10 million versus $7 million in the prior period. The increase in non-operating income was primarily driven by higher foreign exchange transactional gains, partially offset by lower equity income due to the prior year sale of an equity interest in an unconsolidated joint venture.

***Tax Expense***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Tax expense | $25 | $24 | $63 | $62 |
| Effective tax rate | 24.5% | 31.6% | 21.8% | 25.4% |

---

The effective tax rates for the three months ended September 30, 2025 and 2024 were 24.5% and 31.6%, respectively. The effective tax rates for the nine months ended September 30, 2025 and 2024 were 21.8% and 25.4%, respectively.

The change in the effective tax rate for the three months ended September 30, 2025, compared to the prior period is primarily related to a decrease in U.S. taxes on international operations and the global mix of earnings.

The change in the effective tax rate for the nine months ended September 30, 2025, compared to the prior period is primarily related to a one-time benefit attributable to the revaluation of deferred tax assets in China.

The Organization for Economic Cooperation and Development reached agreement among over 140 countries to implement a minimum 15% tax rate on certain multinational enterprises, commonly referred to as Pillar Two. Many countries we operate in continue to announce changes in their tax laws and regulations based on the Pillar Two framework. While we continue to evaluate the impact of these legislative changes as additional guidance becomes available, uncertainty remains regarding the timing and interpretation by tax authorities in affected jurisdictions. For 2025, Pillar Two is not expected to have a material impact to our effective tax rate.

On July 4, 2025, the United States enacted H.R. 1, comprehensive legislation that introduced changes to federal tax law, among other things. We are currently evaluating the implications of the new tax law and its impact on our Consolidated Interim Financial Statements. Further enactment of legislation by jurisdictions in which we do business could also have an impact on our future effective tax rate, tax liabilities, and cash tax.

The effective tax rate can vary from quarter to quarter due to changes in the Company's global mix of earnings, the resolution of income tax audits, changes in tax laws (including updated guidance on U.S. tax reform), deductions related to employee share-based payments, internal restructurings, and pension mark-to-market adjustments.

***Net Income***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Net income | $77 | $52 | $226 | $182 |
| Net income margin | 8.5% | 6.3% | 8.4% | 6.9% |

---

------

Net income for the three months ended September 30, 2025, increased by $25 million compared with the prior period, primarily due to $20 million of increased gross profit, $8 million of lower interest expense, and a $2 million increase in non-operating income. These were partially offset by $4 million of increased SG&A expense and $1 million of higher tax expense.

Net income for the nine months ended September 30, 2025, increased by $44 million compared with the prior period, primarily due to $47 million of lower interest expense, $23 million of increased gross profit, $3 million of lower SG&A expense, and a $3 million increase in non-operating income. These were partially offset by $4 million of higher other expense, net and the prior year gain of $27 million on the sale of an equity interest in an unconsolidated joint venture.

**Non-GAAP Measures**

It is management's intent to provide non-GAAP financial information to supplement the understanding of our business operations and performance, and it should be considered by the reader in addition to, but not instead of, the financial statements prepared in accordance with GAAP. Each non-GAAP financial measure is presented along with the most directly comparable GAAP measure so as not to imply that more emphasis should be placed on the non-GAAP measure. The non-GAAP financial information presented may be determined or calculated differently by other companies and may not be comparable to other similarly titled measures used by other companies. Additionally, the non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation from, or as a substitute for, an analysis of the Company's operating results as reported under GAAP.

***EBIT and Adjusted EBIT***

In 2025, we revised our non-GAAP reporting metric, transitioning from Adjusted EBITDA to Adjusted EBIT. This change is intended to better reflect our core operating performance and align with industry practices. We believe this change will provide investors with a clearer understanding of our ongoing operational performance.

We define "EBIT" as our net income calculated in accordance with U.S. GAAP, plus the sum of (i) interest expense net of interest income and (ii) tax expense. We define "Adjusted EBIT" as EBIT, plus the sum of (i) repositioning costs, (ii) foreign exchange (gain) loss on debt net of related hedging (gains) losses, (iii) discounting costs on factoring, (iv) gain on sale of equity investment, (v) acquisition and divestiture expenses, (vi) other non-operating income, (vii) capital structure transformation expenses, (viii) debt refinancing and redemption costs, and (ix) loss on extinguishment of debt, if any. We believe that EBIT and Adjusted EBIT are important indicators of operating performance and provide useful information for investors because:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• EBIT and Adjusted EBIT exclude the effects of income taxes, as well as the effects of financing activities by eliminating the effects of interest and therefore more closely measure our operational performance; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• certain adjustment items, while periodically affecting our results, may vary significantly from period to period and could therefore have a disproportionate effect in a given period, affecting the comparability of our results.

The following table reconciles Net income under GAAP to Adjusted EBIT:

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Net income | $77 | $52 | $226 | $182 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net of interest income <sup>(1)</sup>  | 28 | 37 | 80 | 127 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tax expense | 25 | 24 | 63 | 62 |
| EBIT | 130 | 113 | 369 | 371 |
| &nbsp;&nbsp;&nbsp;&nbsp;Repositioning costs <sup>(2)</sup> | 3 | 4 | 8 | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange gain on debt, net of related hedging loss |  |  |  | (1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Factoring and notes receivables discount fees |  | 1 | 2 | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of equity investment |  |  |  | (27) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other non-operating income <sup>(3)</sup> | (1) | (1) | (4) | (4) |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt refinancing and redemption costs <sup>(4)</sup> | 1 |  | 7 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition and divestiture expenses |  |  | 6 | 1 |
| Adjusted EBIT | $133 | $117 | $388 | $361 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Reflects interest income of $1 million and $0 million for the three months ended September 30, 2025 and 2024, respectively, and $3 million and $3 million for the nine months ended September 30, 2025 and 2024, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Repositioning costs includes severance costs related to restructuring projects to improve future productivity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)Reflects the non-service component of net periodic pension income.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)Reflects third-party costs directly attributable to the refinancing of our credit facilities and any amendments.

***Adjusted EBIT for the Three Months Ended September 30, 2025***

![Q3 2025 Adj EBIT Walk.jpg](gtx-20250930_g3.jpg)

For the three months ended September 30, 2025, net income increased by $25 million versus the prior period as discussed above within *Results of Operations for Three and Nine Months Ended September 30, 2025*.

Adjusted EBIT increased by $16 million compared to the prior period, driven by $28 million of higher sales volumes, $11 million of productivity, net of labor inflation and higher stock based compensation, $9 million of foreign currency impacts, $7 million of commodity, transportation and energy deflation and $6 million lower R&D costs. These increases were partially offset by $28 million of unfavorable product mix and $17 million of lower pricing net of inflation pass-through.

During the three months ended September 30, 2025, we saw growth in gasoline from new application launches and program ramp-ups in Europe, China, India and North America. Volumes for diesel and commercial vehicles also increased due to higher demand in Europe and North America, and the launch of an on-highway program in Europe, respectively. Aftermarket volumes, however, showed continued softness primarily due to lower demand for off-highway replacement

------

parts in North America. The combination of these volume dynamics, led by the strong growth in gasoline, resulted in an unfavorable product mix.

The increased productivity from our ability to flex our variable cost structure while driving sustained fixed cost productivity was partially offset by year-over-year labor inflation and higher stock based compensation.

Gains in foreign currency from translational, transactional, and hedging effects in the three months ended September 30, 2025, primarily driven by a higher Euro-to-U.S. dollar versus the prior period, accounted for a $9 million increase in Adjusted EBIT.

***Adjusted EBIT for the Nine Months Ended September 30, 2025***

![Q3 2025 YTD Adj EBIT Walk.jpg](gtx-20250930_g4.jpg)

For the nine months ended September 30, 2025, net income increased by $44 million versus the prior period as discussed above within *Results of Operations for Three and Nine Months Ended September 30, 2025*.

Adjusted EBIT increased by $27 million compared to the prior year, mainly from $40 million of productivity, net of labor inflation and higher stock based compensation, $22 million of higher sales volumes from gasoline and commercial vehicles, $20 million of commodity, transportation, and energy deflation, $13 million of favorable foreign exchange impacts and $7 million of lower R&D costs. These increases were partially offset by $60 million of unfavorable product mix and $15 million of pricing net of inflation pass through.

During the nine months ended September 30, 2025, we saw growth in gasoline from new application launches and program ramp-ups in Europe, North America and India. Volumes for commercial vehicles also increased due to a launch of an on-highway program in Europe and partial recovery of prior year softness in the construction and agriculture industries. Aftermarket volumes, however, showed continued softness primarily due to lower demand for off-highway replacement parts in North America. The combination of these volume dynamics resulted in an unfavorable product mix.

The increased productivity from our ability to flex our variable cost structure while driving sustained fixed cost productivity was partially offset by year-over-year labor inflation.

Gains in foreign currency from translational, transactional, and hedging effects in the nine months ended September 30, 2025, primarily driven by a higher Euro-to-U.S. dollar versus the prior period, accounted for a $13 million increase in Adjusted EBIT.

------

**Liquidity and Capital Resources**

***Overview***

---

| | | |
|:---|:---|:---|
| | **September 30,<br>2025** | **December 31,<br>2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Cash and cash equivalents | $230 | $125 |
| Restricted cash | 2 | 1 |
| Revolving Facility - available borrowing capacity | 630 | 600 |
| Revolving Facility - borrowings or letters of credit outstanding |  |  |
| Term Loan Facilities - principal outstanding | 688 | 692 |
| Senior Notes - principal outstanding | 800 | 800 |
| Bilateral letter of credit facility - utilized capacity | 9 | 8 |

---

On January 30, 2025, we entered into the Restatement Agreement, which amends and restates the Existing Credit Agreement, under which we refinanced in full our $692 million 2021 Dollar Term Facility with a new 2025 Dollar Term Facility in an aggregate principal amount of $692 million. The 2025 Dollar Term Facility will mature on January 30, 2032, and initially bore interest at a spread equal to, at our option, the Adjusted Term SOFR Rate plus 2.25% per annum in the case of Term Benchmark Loans and the Alternate Base Rate plus 1.25% per annum in the case of ABR Loans. We also replaced our existing $600 million revolving facility under the Existing Credit Agreement with the New Revolving Facility under the Credit Agreement in an aggregate principal amount of $630 million. The maturity date of the New Revolving Facility is January 30, 2030.

On August 6, 2025, we entered into the First Amendment to the Restatement Agreement, which reduced the Applicable Rate to the Adjusted Term SOFR Rate plus 2.00% per annum in the case of Term Benchmark Loans and the Alternate Base Rate plus 1.00% per annum in the case of ABR Loans.

During the nine months ended September 30, 2025, we paid cash dividends of $36 million. On October 23, 2025, we declared a cash dividend of $0.08 per share of Common Stock, payable on December 15, 2025, to shareholders of record as of December 1, 2025.

We employ several means to manage our liquidity, and our sources of financing include cash flows from operations, cash and cash equivalents on hand, the 2032 Senior Notes, and our Credit Agreement, including our 2025 Dollar Term Facility and our New Revolving Facility. We expect to continue investing in our facilities as we expand our manufacturing capacity for new product launches and invest in new technologies and strategic growth opportunities, in particular in connection with our zero-emission technologies. We believe the combination of expected cash flows, the term loan borrowings, the 2032 Senior Notes, and the New Revolving Facility, will provide us with adequate liquidity to support the Company's operations.

***Share Repurchase Program***

On December 4, 2024, the Board of Directors authorized a $250 million share repurchase program valid from January 1, 2025, until December 31, 2025. During the nine months ended September 30, 2025, we repurchased $136 million of Common Stock, with $114 million remaining under the share repurchase program as of that date. These repurchases include a total of 5 million shares repurchased from funds affiliated with Oaktree Capital Management, L.P., a related party, for approximately $62 million. We may repurchase shares from time to time under the program through various methods, including in open market transactions, block trades, privately negotiated transactions, and otherwise. The timing, as well as the number and value of shares repurchased under the program, will depend on a variety of factors. We are not obligated to purchase any shares under the share repurchase program, and the program may be suspended, modified, or discontinued at any time without prior notice. For more information, see Item 2. *Unregistered Sales of Equity Securities and Use of Proceeds*.

------

***Cash Flow Summary for the Nine Months Ended September 30, 2025***

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Cash provided by (used for): |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating activities | $314 | $277 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investing activities | (27) | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Financing activities | (187) | (439) |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of exchange rate changes on cash and restricted cash | 6 | (2) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | $106 | $(163) |

---

Cash provided by operating activities increased by $37 million for the nine months ended September 30, 2025, versus the prior year. The increase was primarily driven by $44 million of higher net income and $39 million of favorable impacts from working capital changes, partially offset by a decrease of $34 million of non-cash charges and $12 million of unfavorable impacts from changes in other assets and liabilities.

Cash flow used for investing activities decreased by $28 million for the nine months ended September 30, 2025, compared to the same period in the prior year. The decrease was primarily driven by $46 million in proceeds from the sale of our unconsolidated joint venture realized in the prior year, along with $3 million in reduced proceeds from the cross currency swap. These impacts were partially offset by $18 million in lower capital expenditures on property, plant and equipment and $3 million received for the first deferred payment on the sale of our unconsolidated joint venture.

Cash used for financing activities was $187 million for the nine months ended September 30, 2025, compared with $439 million in the prior year. During the nine months ended September 30, 2025, we made debt repayments of $87 million, payments of $136 million for the repurchase of Common Stock under our share repurchase program and payments of $36 million for dividends on our Common Stock. These payments were partially offset by proceeds of $80 million from the Credit Facilities.

In comparison, cash used for financing activities was $439 million for the nine months ended September 30, 2024 primarily driven by aggregate debt repayments of $991 million on our credit facilities. We also made payments of $226 million for Common Stock repurchases, $7 million for debt issuance costs and $9 million for other financing activities. These payments were partially offset by proceeds of $794 million, net of deferred financing costs, from the issuance of our 2032 Senior Notes.

**Off-Balance Sheet Arrangements**

We do not engage in any off-balance sheet financial arrangements that have or are reasonably likely to have a material current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources.

**Critical Accounting Policies** 

The preparation of our Consolidated Interim Financial Statements in accordance with GAAP is based on the selection and application of accounting policies that require us to make significant estimates and assumptions about the effects of matters that are inherently uncertain. Actual results could differ from our estimates and assumptions, and any such differences could be material to our financial statements. Our critical accounting policies are summarized in the "Management's Discussion and Analysis of Financial Condition and Results of Operations" section of our 2024 Form 10-K.

***Recent Accounting Pronouncements***

See Note 2, *Summary of Significant Accounting Policies* of the Notes to the Consolidated Interim Financial Statements for further discussion of recent accounting pronouncements.

------

**Special Note Regarding Forward-Looking Statements**

This Quarterly Report on Form 10-Q and the other reports filed by us with the SEC from time to time, as well as statements incorporated by reference herein and related comments by our management, contain forward-looking statements within the meaning of the U.S. federal securities laws. All statements other than statements of historical fact, including without limitation statements regarding our future results of operations and financial position, expectations regarding the growth of the turbocharger and electric vehicle markets and other industry trends, the sufficiency of our cash and cash equivalents, anticipated sources and uses of cash, anticipated investments in our business, our business strategy, pending litigation, anticipated interest expense, and the plans and objectives of management for future operations and capital expenditures are forward-looking statements. In many cases, you can identify forward-looking statements by terms such as "aim," "anticipate," "appears," "approximately," "believe," "continue," "could," "designed," "effect," "estimate," "evaluate," "expect," "forecast," "goal," "initiative," "intend," "may," "objective," "outlook," "plan," "potential," "priorities," "project," "pursue," "seek," "should," "target," "when," "will," "would," or the negative of these terms or other similar expressions. In making these forward-looking statements, we rely on our current expectations and projections about possible future events and financial trends that we believe may affect our business, financial condition and results of operations. We believe these judgments are reasonable, but these statements are not guarantees of any future events or financial results, and our actual results may differ materially due to a variety of important factors, many of which are beyond our control. These factors, which may be revised or supplemented in subsequent reports we file with the SEC, include, among other things, risks related to the following: (1) the ongoing evolution of the automotive industry; (2) the highly competitive markets in which we operate; (3) our reliance on sales to major customers; (4) changing industry and economic conditions; (5) the unique aspects of our aftermarket business; (6) pricing pressures from our original equipment manufacturer customers; (7) the foreign markets in which we operate; (8) climate change and increased scrutiny from customers, investors, regulators and other stakeholders; (9) recruitment, development, and retention of qualified personnel; (10) program launch difficulties; (11) volatility in the cost of raw materials, components, energy, transportation, and other inputs; (12) supply shortages or supplier distress leading to a disruption of our operations; (13) realization of sales from awarded business; (14) economic, political, regulatory, foreign exchange and other risks of our international operations; (15) geopolitical conditions, catastrophic events and pandemics; (16) joint venture partnerships, joint development projects and other strategic opportunities; (17) intellectual property rights; (18) work stoppages or other disruptions at our facilities; (19) realization of productivity and efficiency improvements and repositioning projects; (20) warranty claims, product recalls, field actions or product liability actions; (21) litigation, government proceedings and other contingencies and uncertainties; (22) environmental matters and liabilities; (23) third-party licensing arrangements; (24) information technology and data privacy considerations, including cybersecurity and other security concerns; (25) our substantial indebtedness and restrictive covenants related to such indebtedness; (26) tax considerations; (27) our ability to raise capital; (28) our pension funding obligations; (29) concentration of ownership of our equity securities; or (30) payment of dividends and share repurchases. For a further discussion of these and other risks, refer to Part I, Item 1A. "Risk Factors" of our 2024 Form 10-K.

You should read this Quarterly Report and the documents that we reference herein completely and with the understanding that our actual future results may be materially different from those envisioned by these forward-looking statements. We qualify all of our forward-looking statements by these cautionary statements. These forward-looking statements speak only as of the date of this Quarterly Report. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances, or otherwise.

**Item 3. Quantitative and Qualitative Disclosures About Market Risk**

As of September 30, 2025, the net fair value of all financial instruments with exposure to currency risk was $164 million. The potential loss or gain in fair value for such financial instruments from a hypothetical 10% adverse or favorable change in quoted currency exchange rates would be $271 million and $(268) million, respectively, as of September 30, 2025, exchange rates. The model assumes a parallel shift in currency exchange rates; however, currency exchange rates rarely move in the same direction. The assumption that currency exchange rates change in a parallel fashion may overstate the impact of changing currency exchange rates on assets and liabilities denominated in currencies other than the U.S. dollar.

There have been no other material changes to the Company's quantitative and qualitative disclosures about interest rate or commodity price risks as disclosed in Part II, Item 7A, *Quantitative and Qualitative Disclosures About Market Risks*, in our 2024 Form 10-K.

------

**Item 4. Controls and Procedures**

In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) promulgated under the Exchange Act. Based on management's evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of September 30, 2025.

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended September 30, 2025, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

**PART II—OTHER INFORMATION**

**Item 1. Legal Proceedings**

We are involved in various lawsuits, claims, and proceedings incident to the operation of our businesses, including those pertaining to product liability, product safety, environmental, safety and health, intellectual property, employment, commercial and contractual matters, and various other matters. Although the outcome of any such lawsuit, claim or proceeding cannot be predicted with certainty and some may be disposed of unfavorably to us, we do not currently believe that such lawsuits, claims, or proceedings will have a material adverse effect on our financial position, results of operations or cash flows. We accrue for potential liabilities in a manner consistent with accounting principles generally accepted in the United States. Accordingly, we accrue for a liability when it is probable that a liability has been incurred and the amount of the liability is reasonably estimable.

For additional information regarding our legal proceedings, see the discussion under Note 19, *Commitments and Contingencies* of the Notes to the Consolidated Interim Financial Statements, which is incorporated by reference into this Part II, Item 1.

**Item 1A. Risk Factors**

There have been no material changes to the risks described under "Risk Factors" in our 2024 Form 10-K. In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed under "Risk Factors" in our 2024 Form 10-K. These factors could materially adversely affect our business, financial condition, or results of operations, and could cause our actual results to differ materially from our historical results or the results contemplated by any forward-looking statements contained in this report.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds**

On December 4, 2024, the Board of Directors authorized a $250 million share repurchase program valid from January 1, 2025, until December 31, 2025. The Company may repurchase shares from time to time under the program through various methods, including in open market transactions, block trades, privately negotiated transactions, and otherwise. The timing, as well as the number and value of shares repurchased under the program, will depend on a variety of factors. The Company is not obligated to purchase any shares under the repurchase program, and the program may be suspended, modified, or discontinued at any time without prior notice. The following table summarizes our share repurchase activity for the three months ended September 30, 2025, and additional information regarding our share repurchase program:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total Number of Common Shares Purchased** <sup>(1)</sup> | **Average Price Paid per Share** | **Total Number of Shares Purchased as Part of Publicly Announced Plan or Program** | **Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plan or Program** |
| July 1, 2025 - July 31, 2025 | 187381 | 10.74 | 187381 | $196292875 |
| August 1, 2025 - August 31, 2025 | 5799335 | 12.50 | 5799335 | 123823380 |
| September 1, 2025 - September 30, 2025 | 723681 | 13.15 | 723681 | 114303798 |
| Total | 6710397 | $12.52 | 6710397 | $114303798 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Excludes shares withheld to satisfy tax withholding obligations in connection with the vesting of equity awards.

Other than the repurchases reflected in the table above, there were no purchases of equity securities by the issuer or affiliated purchasers during the quarter ended September 30, 2025.

**Item 3. Defaults Upon Senior Securities**

Not applicable.

------

**Item 4. Mine Safety Disclosures**

Not applicable.

**Item 5. Other Information**

*Trading Agreements*

During the three months ended September 30, 2025, no director or Section 16 officer of the Company adopted or terminated a "Rule 10b5-1 trading agreement" or "non-Rule 10b5-1 trading agreement," as each term is defined in Item 408(a) of Regulation S-K.

**Item 6. Exhibits**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | |
| **Exhibit**<br>**Number** | **Description** | **Form** | **File No.** | **Exhibit** | **Filing**<br>**Date** | **Filed/ Furnished**<br>**Herewith** |
| 3.1 | <u>[Third Amended and Restated Certificate of Incorporation of Garrett Motion Inc., dated May 29, 2024](https://www.sec.gov/Archives/edgar/data/1735707/000173570724000044/exhibit3_1-garrettmotionxt.htm)</u> | 10-Q | 001-38636 | 3.1 | 07/25/2024 |  |
| 3.2 | <u>[Fifth Amended and Restated By-Laws of Garrett Motion Inc., dated May 29, 2024](https://www.sec.gov/Archives/edgar/data/1735707/000173570724000044/exhibit3_2-garrettmotionxf.htm)</u> | 10-Q | 001-38636 | 3.2 | 07/25/2024 |  |
| 10.1 | <u>[First Amendment](https://www.sec.gov/Archives/edgar/data/1735707/000095014225002112/eh250664811_ex1001.htm)[, dated as of](https://www.sec.gov/Archives/edgar/data/1735707/000095014225002112/eh250664811_ex1001.htm)[August](https://www.sec.gov/Archives/edgar/data/1735707/000095014225002112/eh250664811_ex1001.htm)[6](https://www.sec.gov/Archives/edgar/data/1735707/000095014225002112/eh250664811_ex1001.htm)[, 2025, to](https://www.sec.gov/Archives/edgar/data/1735707/000095014225002112/eh250664811_ex1001.htm)[Amended and Restated](https://www.sec.gov/Archives/edgar/data/1735707/000095014225002112/eh250664811_ex1001.htm)[Credit Agreement, dated as of](https://www.sec.gov/Archives/edgar/data/1735707/000095014225002112/eh250664811_ex1001.htm)[January](https://www.sec.gov/Archives/edgar/data/1735707/000095014225002112/eh250664811_ex1001.htm)[30, 202](https://www.sec.gov/Archives/edgar/data/1735707/000095014225002112/eh250664811_ex1001.htm)[5](https://www.sec.gov/Archives/edgar/data/1735707/000095014225002112/eh250664811_ex1001.htm)[, among Garrett Motion Inc., Garrett LX I S.à r.l., Garrett Motion Holdings, Inc., Garrett Motion Sàrl, the lenders and issuing banks party thereto, and JPMorgan Chase Bank, N.A., as administrative agent.](https://www.sec.gov/Archives/edgar/data/1735707/000095014225002112/eh250664811_ex1001.htm)</u> | 8-K | 001-38636 | 10.1 | 08/07/2025 |  |
| 31.1 | <u>[Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](exhibit31_1-exx3112025q3.htm)</u> |  |  |  |  | \* |
| 31.2 | <u>[Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](exhibit31_2-exx3122025q3.htm)</u> |  |  |  |  | \* |
| 32.1 | <u>[Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](exhibit32_1-exx3212025q3.htm)</u> |  |  |  |  | \*\* |
| 32.2 | <u>[Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](exhibit32_2-exx3222025q3.htm)</u> |  |  |  |  | \*\* |
| 101 | The following financial information from the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, formatted in Inline Extensible Business Reporting Language (iXBRL) includes: (i) the Consolidated Interim Statements of Operations, (ii) the Consolidated Interim Statements of Comprehensive Income, (iii) the Consolidated Interim Balance Sheets, (iv) the Consolidated Interim Statements of Cash Flows, (v) the Consolidated Interim Statements of Equity (Deficit) and (vi) Notes to the Consolidated Interim Financial Statements |  |  |  |  | \* |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |  |  |  |  | \* |

---

------

\* Filed herewith.

\*\* Furnished herewith.

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | Garrett Motion Inc. | Garrett Motion Inc. |
| Date: October 23, 2025 | By: | /s/ Olivier Rabiller |
|  |  | **Olivier Rabiller** |
|  |  | **President and Chief Executive Officer** |
| Date: October 23, 2025 | By: | /s/ Sean Deason |
|  |  | **Sean Deason** |
|  |  | **Senior Vice President and Chief Financial Officer** |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION** 

I, Olivier Rabiller, certify that:

1.&nbsp;&nbsp;&nbsp;&nbsp;I have reviewed this Quarterly Report on Form 10-Q of Garrett Motion Inc.;

2.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: October 23, 2025 | By: | /s/ Olivier Rabiller |
|  |  | Olivier Rabiller |
|  |  | President and Chief Executive Officer |
|  |  | *(principal executive officer)* |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION** 

I, Sean Deason, certify that:

1.&nbsp;&nbsp;&nbsp;&nbsp;I have reviewed this Quarterly Report on Form 10-Q of Garrett Motion Inc.;

2.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: October 23, 2025 | By: | /s/ Sean Deason |
|  |  | Sean Deason |
|  |  | Senior Vice President and Chief Financial Officer |
|  |  | (*principal financial officer*) |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report on Form 10-Q of Garrett Motion Inc. (the "Company") for the period ended September 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: October 23, 2025 | By: | /s/ Olivier Rabiller |
|  |  | Olivier Rabiller |
|  |  | President and Chief Executive Officer <br>(*principal executive officer*) |

---

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report on Form 10-Q of Garrett Motion Inc. (the "Company") for the period ended September 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: October 23, 2025 | By: | /s/ Sean Deason |
|  |  | Sean Deason |
|  |  | Senior Vice President and Chief Financial Officer<br>(*principal financial officer)* |

---

<br>